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TB is a common disease and leading causes of mortality due to communicable diseases. 
Research has been going to find the nature of the disease as well to find new technique that could 
give us a leading edge in cracking this disease in an early stage.recently a number of nucleic acid 
amplification assays have been employed to detect the mycobacterium tuberculosis in clinical 
specimens, among these loop mediated isothermal amplification posess superior reaction 
characteristics 
in the present study we evaluate a LAMP method to identify the MTB specific IS6110 
gene among 50 sputum samples collected from patients suspected of tuberculosis in tirunelveli 
medical college and compare them with gold standard “culture on lowenstein jenson media” for 
8 weeks .the study showed the LAMP method has an excellent sensitivity of 95% and specificity 
of 79% which shows that this method in conjunction with smear microscopy can be a powerful 
tool in the early detection of TB. 
 Introduction: 
Tuberculosis is disease known since ancient times. The earliest discovery dates back to 6000 
years ago among the human remains in Egypt1. It was also isolated from the mummies around 
2400-3000 B.C. Its also a disease which has defied the scientific achievements and miraculous 
cure for so many diseases that modern medicine was able to do in last century. The 
immunology and understanding of infectious diseases started with the identification of bacteria 
under a microscope by Anton Van Leewenhouk in the 16th century.its to be noted that earlier 
systems of medicine such as the greek, Persian medicine though formulated that certain 
diseases are contagious and are transmitted by “invisible particles”, the modern medicine or the 
western medical system proved a breakthrough in making these “invisible particles” as visible. 
Since Koch's discovery of the TB bacilli in 1882, microscopic detection of the bacilli in clincal 
specimens has remained as the cornerstone of TB diagnosis in low and middle income 
countries. 
Many of us would know that the killer diseases of ancient times such as anthrax, plague, small 
pox were almost eradicated from the face of the earth by the deeper understanding of science, 
how our body reacts to foreign agents, the discovery of penicillin and so on..only a few 
infectious diseases still exist which defies the human developments...it would not be an 
exaggeration to say that though effective treatments, diagnostic methods had been evolved to 
tackle tuberculosis it is still largely “invisible” or undetected. 
The statistics by the world health organization says that one third of every human being in this 
world is infected with Mycobacterium tuberculosis 3,4. not to say its more prevalent in 
developing countries or the “third world countries”.this disparity in its geographical 
distribution is due to the poor living conditions, inadequate housing, poor sanitation, 
malnutrition and to a greater extent on the health care measures taken by the respective 
governments. 
India is one of world's nest in tuberculosis an estimated 2 patients per second die of 
tuberculosis5. And the post independent India started its national tuberculosis program since 
1962 which was evolved in to the revised national tuberculosis control program in 1992 with 
the help of international agencies and adopted the international strategy of DOTS-direct 
observed short term treatment strategy5. 
The importance of tuberculosis and the need for further research into it is obligated by its 
“invisible nature”.why it is said as “invisible”? Because the difficulties in the diagnosis 
whether clinical or non clinical. In clinical spectrum the diagnosis includes symptoms such as 
cough with expectoration for more than 2 weeks, evening rise in temperature, night sweats, loss 
of weight and appetite and radiologically in finding any cavitary lesions in the lungs. In 
microbiology the diagnosis includes the classical acid fast staining method, the gold standard 
culture on solid media. The developments in molecular biology and the development of 
polymerase chain reaction has made numerous strides in the field of microbiology in 
diagnosing infectious diseases. Scientists have gone to the extent of describing the era of 
molecular biology as “before PCR” and “after PCR”. 
The PCR techniques enables to diagnose small quantities of the infectious material and has 
proved to be a good diagnostic method in terms of sensitivity, specificity and rapidness. 
However they are not without negatives. The negatives include its cost, and cannot differentiate 
between live or dead organisms. 
The PCR technique originally developed by Kary Mullis in 1983 was based on amplifying a 
single gene or a few gene to many fold times , thereby enabling to identify them. He used a 
polymerase enzyme taq polymerase isolated from the thermophilic bacterium thermus 
aquaticus. Infact the process is named after that enzyme. Since then the process has been used 
in a wide variety of applications such as gene cloning, DNA fingerprinting and to identify 
infectious organisms. The method relies on the thermal cycling and enzymatic replication of the 
DNA. Primers which are short DNA fragments which are complementary to the target gene 
along with the polymerase enzyme make this possible. 
It is to be noted that PCR is not without errors, the polymerase enzyme can mutate the PCR 
fragments made and hence affect their specificity. 
The technique has been evolved into many variations and one of the variations is loop mediated 
isothermal amplification. This LAMP technique employs a Bst polymerase extracted from 
bacillus stearothermophilus. Incontrast to the conventional PCR which uses thermocycling, this 
technique could be done in a constant temperature. This is made possible by using a 
polymerase enzyme with a high strand displacement activity in addition to the replication 
activity. Typically 4 different sets of primers are used to amplify six different areas of the target 
gene which adds to their specificity. A large number of copies are made and their diagnosis is 
done with naked eye due to the increased precipitation of magnesium pyrophosphate which is a 
byproduct of the amplification. It can also be detected via photometry .dyes such as a SYBR 
green can be used to intercalate the amplified DNA and hence by measuring the colour change 
its possible to quantitate the reaction as well. 
By eliminating the use of costly thermocyclers this technique promises a great and low cost 
alternative in diagnosing infectious diseases. The laboratory diagnostic method include Ziehl-
Neelson acid fast staining which is routinely used in all the primary health care centers in India. 
However the sensitivity of the test is only 30%, thereby missing a huge chunk of the positive 
patients. Culture on the other hand is the “gold standard” but it needs sophisticated centers with 
biosafety levels and the result cannot be achieved unless 8 weeks which is huge time for which 
the treatment cannot be delayed. The skin test can determine the immune status of the 
individual and cannot determine if he's suffering from active diseases or had previous 
immunization, nevertheless its useful in screening purposes. The RNTCP has achieved great 
lengths in combating tuberculosis in India, nevertheless the gaps in diagnosing the infection 
still remains a hurdle. 
In India 40% of population are infected with tuberculosis with a lifetime risk of 100% even in 
the absence of HIV. The emergence of HIV has made the TB/HIV a dreadful combination as 
HIV itself is not a killer disease while it lowers the immunity, thereby making tuberculosis an 
opportunistic infection and thus the rates of Tuberculosis in patients infected with HIV has 
soared. One more thing which is of great concern is the emergence of the “super bugs”, which 
is the multidrug resistance Tuberculosis which has higher mortality and morbidity. The RNTCP 
has launched PCR based techniques in detecting the above two clauses which is CBNAAT 
which is cartridge based nucleic acid amplification techniques. This has been accepted 
worldwide to detect Mycobacterium tuberculosis. But their role in screening Mycobacterium 
tuberculosis and detecting it in patients in outpatient setting has seen limitations owing to the 
higher costs and still needs further evaluation and research regarding the same. The present 
study aims to find the efficacy of this newer technique the “loop mediated isothermal 
amplification” in the detection of Mycobacterium tuberculosis in clinical specimens. as 
tuberculosis remains as one of the diseases which needs a definitive control strategy numerous 
















Aims and objective: 
aim of the study: 
To find a low cost, rapid and efficient microbiological diagnostic method for the detection of 
Mycobacterium tuberculosis from clinical specimens that could be implemented without much 
training and even in a rural setting 
objective: 
to evaluate the sensitivity, specificity of loop mediated isothermal amplification in sputum 
samples collected from both smear positive, smear negative specimens in a blinded study and 















Review of literature: 
Epidemiology: 
According to ICMR bulletin dated august 2002, 
about one third of the worlds population is infected with tuberculosis. 
Around 10 million people acquire tuberculosis annually and 3 million people die of the disease 
each year. 
Mortality for tuberculosis is 25% of all avoidable deaths. 
95% of all TB cases and 98% of death due to TB are in developing countries which includes 
India, and among them 75% are in economically active age group. 
In India around 2 million people acquire the disease annually and of that 1 million people die of 
it each year. 
This means one patient dies of TB every minute. 
To compound this problem, is the emergence of HIV. 
India has 3.5 million HIV patients of which 1.8 million patients have TB. Around 60% of HIV 
patients acquire active TB during their life time7 . 
Its worth to mention the emergence of the super bugs MDR and XDR and their coincidence 
with HIV is nevertheless associated with higher fatality rates. 
Terminology: 
TB incidence: number of new cases of active TB /year 
TB prevalence: number of people living with active TB 
the revised national tuberculosis control programme was launched in india in 1997. 
Definition: 
TB relapse: if the patient becomes ill after finishing the first course of treatments 
Treatment failure: some improvement or total failure to respond to treatment 
Default: patients who havent finished the first course of treatments 
all the above three categories can develop drug resistance and need drug susceptibility testing . 
Exposure to TB depends upon the following factors: 
1) number of active cases in a community 
2) duration of their infection 
3) number and nature of interaction between the active case and contacts in a given time. 
The above facts were derived from Tbfacts.org 
in a study by Dr.William W Stead in the annals of internal medicine say that “ person who react 
after exposure of tuberculosis fall into three types.the reaction here is tuberculin sensitivity test. 
1)patients who have positive TST and have a high risk of tuberculosis , they need prophylaxis 
2) patients where there is no screening done before exposure and are positive to TST should be 
treated as like above said 
3)  people who are positive to TST but the risk is too low..they dont need prophylaxis” 
corresponding to the topic I am quoting another study which is worth when considering the 
screening in epidemics and health care workers8. 
In a study by Peter E Sokolovo in the annals of the internal medicine finds that” systematic 
monitoring by tuberculin sensitivity testing is necessary to find the adequacy of respiratory 
isolation procedures carried out in the emergency department of a hospital during epidemics.” 
smoking is a known risk factor which predisposes to tuberculosis.10 
In a study by Dr.C.Kolappan from the tuberculosis research center, ICMR published in british 
medical journal of thorax says that “ the association between tuberculosis and smoking is a 
strong dose-response relationship”.11 
there's some good news.by implemeting effective diagnosis and treatment strategies a few 
countries have been able to bring down TB.eg: china,brazil and cambodia.11 
Causative organism: 
Scientific work suggests that Mycobacterium tuberculosis evolved from a common human 
specific pathogen about 40000 years ago. .the evolution of the TB bacilli is closed linked with 
migration of human beings out of africa .the bovis species evolution has been linked with the 
domestication of animals.12 
The tubercle bacilli is an aerobic ,acid fast bacilli.the acid fastness is due to the peptidogylcan 
layer linked with the mycolic acid in the cell wall. This arrangement is one of the virulent 
characters of the organism as its difficult for the antibiotics to penetrate the cell wall and to the 
action of the antibodies..cell wall has another component , lipoarabinomannan which eases the 
intracellular survival of the organism. 
Regarding the evolution of TB bacilli, In a study by cristina gutierrraz ,the author says that 
“scientists show that the TB bacilli is able to exchange parts of their genome with other 
bacteria , which makes them adaptable to specific hosts”. 
Transmission: 
TB is a disease thats spread by aerosols.factors which influence the transmission are 
1) Ventilation in the room 
2) Number of bacilli in the droplet 
3)Exposure to UV rays 
primarily its a disease affecting the lungs . 
Greek physician and the father of medicine Hippocrates said phthisis, the other name for 
tuberculosis as “ulceration of lungs, thorax accompanies by cough, fever, and consumption of 
the body by pus”.13 
No wonder the disease was also called a consumption disease. 
In a study by Sheela V.Shenoi et al in the journal of current HIV reports in 2013 says that 
“prevention of tuberculosis requires airborne infection control methods and such methods have 
been ignored and with grave consequences”.14 
In yet another study by Riley et al published in the American journal of epidemiology 




In a study by parsons et al on the laboratory diagnostic aspects of drug resistant TB states “the 
main reasons for the requirement of multiple drugs to effectively cure Tb is because of the 
hydrophobic cell envelope surrounding members of the Mycobacterium tuberculosis complex 
that serves as a permeability barrier to many compounds; the sequestered, non replicating sub 
population of TB that is affected by drugs only when the cells reemerge from dormancy; and 
the drug target or drug activating enzymes in TB that are altered by mutation and result in a 
population of drug resistant cells”.16 
The primary defense system is the airway itself. The infectious droplets when inhaled are 
caught in the mucus secreted by the goblet cells of the respiratory tract. the cilia present in 
columnar epithelium push the trapped bacilli upwards by their movement. 
Those bacilli which escape this primary defense mechanism are engulfed by the alveolar 
macrophages which are present in the lungs. This is the second life of defense. Macrophages 
are cells which need no previous exposure to get sensitized. The action of macrophages starts a 
chain of events which result in either containing the infection or the bacilli able to withstand 
this defense too. At last to be an active disease all depends on this delicate balance, the 
immunity of the body and the invading bacteria. 
Inside the macrophages the bacteria continue to multiply, the macrophages began to release a 
few immune markers like cytokines and proteolytic enzymes. This attracts the T lymphocytes 
and marks the cell mediated immunity. This forms the third step of defense. 
The end result of this cell mediated immunity is destruction of the lesion (granuloma) into a 
necrosis, in some cases, the lesion is replaced with fibrosis, while in some cases where the 
immune system is weak the lesion progresses further to primary progressive tuberculosis. 
The TB bacilli is contained within the lesion, which may be activated later when the host 
immune defenses are weak..this dormant lesion is called latent tuberculosis. 
In some cases when the lesion erodes into a blood vessel, the bacteria is carried to distance sites 
producing extra pulmonary tuberculosis. If it enters the lymphatic system, it reaches the 
adjacent lymph nodes producing soft cheese like necrosis called caseating necrosis. 
Clinical features: 
Depends on the stage of tuberculosis 
1) Latent Tuberculosis: MTB can be confined, but difficult to eradicate. Patients with latent 
TB will not have any clinical signs and symptoms. Neither they are infectious. But the bacilli is 
present in them for long time.in case of immunodeficiency as in case of AIDS,diabetes, steroid 
therapy etc the disease may get reactivated .its more common in elderly patients. 
in a study by kiwanuka et al and lama et al says “coinfection with TB has been associated with 
an increased replication of HIV-1 and the development of TB disease during HIV infection 
involves both a reactivation of latent TB and increasingly progressive primary TB”17,18 
2) Primary pulmonary tuberculosis: 
This is usually non symptomatic. Only diagnostic tests can detect the disease. However the 
following findings may be detected in case a patient comes with primary disease: 
Lymphadenopathy, pleural effusion, dyspnoea, fever. 
3) Primary Progressive Tuberculosis: 
Active disease develops in 5-10% of exposed cases. The clinical features are non specific 
during early stages.The C/F include: malaise, fatigue, loss of weight, evening rise in 
temperature associated with night sweating. Wasting is due to altered metabolism, loss of 
appetite. Clubbing due to insufficient oxygenation. The cough is first dry later becomes 
productive. If any blood vessel becomes ruptured, hemoptysis may occur. Blood tests show 
anemia and increased leukocyte count. 
 
4) Extra Pulmonary Tuberculosis: 
It occurs in around 20%  of immunodeficient cases. The commonest forms include, TB 
meningitis, TB spine, miliary TB and lymphatic TB. 
In a study by S.K .Sharma and Mohan et al 
“diagnosing extra pulmonary tuberculosis is very difficult. The recent advances in imaging 
studies can locate the site of infection .with the help of biopsy its possible to isolate the bacilli 
from the lesion”.19 
In a study by Sayantan Rat et al 
“The main event in causing miliary TB is the massive lympho-hematogenous spread of the 
bacilli from a focus to multiple organs. The main organs involve liver, spleen and bone marrow. 
The predilection to these organs is because of many phagocytes in their sinusoidal wall. Miliary 
TB can be due to 
1) Simultaneous reactivation of multiple loci either from primary disease or latent disease 
2) reinfection 
The pathogenecity is because of the insufficient T cell response. in this disease, the recruitment 
of Teff cells fails to provide an adequate level of immunity because of homing of regulatory 
Treg cells which inhibit teff cells”20 
In a study by bourdin trunz et al in the lancet edition of April 2006 studied the effect of BCG 
vaccination in the prevention of TB meningitis and miliary tuberculosis and find that “BCG 
vaccination is a good cost effective intervention against severe forms of TB such as TB 
meningitis and miliary TB and it should be retained in high incidence countries as a strategy to 
supplement the chemotherapy of active tuberculosis”.21 
 
Multi Drug Resistant Tuberculosis: 
Standard anti tuberculosis has been used for many years since the advent of those medicines , 
however the resistance to them have emerged and is now global..there has been resistance at 
least one drug in all the countries with tuberculosis. 
In a study by dorman et al and gandhi NR et al published in lancet states “recently multi drug 
resistant TB and extensive drug resistant TB have had devastating effects on populations of 
HIV infected individuals in developing countries, who ironically had good access to HIV care 
but dies from some untreatable form of TB”.22 
MDR TB, there is resistance to isoniazid and rifampicin, the first line drugs. 
The most common cause of MDR TB is faulty treatment. This type of TB can be cured by 
second line drugs. But these drugs are not easily available. Moreover the medicines in the 
second line had to be taken at least for two years consecutively which can reduce patient 
compliance as well severe side effects. Its to be noted that when starting the primary therapy of 
first line of drugs patient education is important creating awareness regarding faulting 
treatment which the can complicate this disease further. 
More worse than MDR TB is the XDR TB or extreme drug resistant TB which has high 
mortality rates. 
In the study about half a million people worldwide developed MDR TB in 2013. 
HIV and TB: 
Statistics of association between HIV and TB have been described above in the statistics. Its 
noteworthy to mention that the people living with HIV can develop active tuberculosis 26 to 31 
times more than normal population. Also Africa “the dark continent” which has has been 
subject to numerous disease since the origins of mankind is no exception to this association. In 
2013 there were 1.1 million cases of TB among HIV patients , 78% of which were from Africa. 
This may be linked with poor healthcare, AIDS denial ism among many politicians, poverty 
and malnutrition. The origins of AIDS, HIV have been subject to numerous conspiracy theories 
and well disputed by reputed scientists all over the world and the disappearance of over a 100 
microbiologists in the last decade alone, the treatment for AIDS has been disputed among many 
main stream scientists. 
In studies by klautau GB et al and Murray JF et al in 2005 “HIV mediated immunosuppression 
impairs granuloma formation, resulting in both ineffective containment of Mycobacterium 
tuberculosis bacilli and diminished formation of pulmonary cavities” 
in a study by poprawski D in 2000 “the above mentioned effects cause extra pulmonary disease 
in HIV-TB subjects”. 
In further studies by pitchenik AE et al, lee MP et al and colebunders R et al “the HIV-TB 
manifests with atypical chest findings, greater involvement of lower lobes of the lung and 
lower concentration of bacteria in sputum”. 
“The world health organization recommends a 12 component approach of collaborative TB-
HIV activities”. 
In a study by NR Gandhi et al in Lancet says that “MDR tuberculosis is more prevalent than 
previously realized in this setting. XDR tuberculosis has been transmitted to HIV co-infected 
patients and is associated with high mortality. These observations warrant urgent intervention 
and threaten the success of treatment programmes for tuberculosis and HIV”.22 
In another study by Diperri giovani et al in lancet says that “In an investigation of a nosocomial 
outbreak of tuberculosis, 18 HIV-infected inpatients were found to have been exposed 
to Mycobacterium tuberculosis; active tuberculosis developed in 8, 7 within 60 days of 
diagnosis of the index case. The patients with lower total lymphocyte and CD4 lymphocyte 
counts were more likely to get the disease than were those with higher counts. A low score on 
multiple antigen skin testing was also associated with the development of active tuberculosis. 4 
of the 18 patients had a positive tuberculin skin test before exposure to M tuberculosis; none of 
them subsequently got the disease”23 
In a study by karp et al on co infection with HIV and tropical infectious diseases states “much 
of the deadliness of tuberculosis epidemics, especially in sub-Saharan Africa has to do with the 
virulent synergy between HIV and tuberculosis”.24 
According to AIDS epidemic update 2009 and WHO global TB control update 2009 “out of the 
9.27 million incident cases of TB in 2007,an estimated 1.37 million were HIV positive ;79% of 
these HIV positive cases were in the African region and 11% were in south east Asia region”.25 
In a study by Parsons et al in clinical microbiology reviews “an estimated 1.3 million deaths 
occurred among incident TB cases who were HIV positive. Infection with HIV 1 increases the 
risk of reactivating latent TB infection by 80 to 100 fold and HIV patients acquire new TB 
infections have higher rates of TB progression. Tuberculosis can occur at all points in the 
immunosuppressive spectrum of HIV disease with variable presentations and particularly in 
high burden countries TB may be the first presentation of HIV disease”.26 
According to a study by mukadi et al on tuberculosis fatality rates in high hiv prevalence 
populations in sub Saharan Africa “fatality rates are higher for HIV-TB co infected patients 
who are on anti-TB treatment but not on ART than for treated TB patients who are HIV 
negative”.2\7 
In a study by ackah et al on response to treatment, mortality and cd4 lymphocyte counts in HIV 
infected patients with tb in abidjan states that “highest death rates occur in co infected patients 
with lowest CD4 counts”.28 
According to world health organization 
“Latent tuberculosis infection (LTBI) is a state of persistent immune response to stimulation by 
Mycobacterium tuberculosis antigens without evidence of clinically manifested active TB. A 
direct measurement tool for M. tuberculosis infection in humans is currently unavailable. One-
third of the world’s population is estimated to have LTBI: they do not have active TB disease 
but may develop it in the near or remote future, a process called TB reactivation. The lifetime 
risk of reactivation for a person with documented LTBI is estimated to be 5–10%, with the 
majority developing TB disease within the first five years after initial infection. However, the 
risk is considerably higher in the presence of predisposing factors” 
In a study by farba karam et al, 
“The identification and treatment of latent TB infection in HIV positive individuals is one of 
the main recommendations developed by the World Health Organization in order to reduce 
morbidity and mortality in HIV patients living in high TB prevalence areas . Tuberculin skin 
testing has been shown to be highly inadequate for identifying LTBI in HIV infected 
individuals, as the anergy to skin testing may lead to false negative results . More sensitive and 
specific diagnostic tools are therefore urgently required . the study showed that, EC-
ELISPOT(enzyme linked immuno spot) assay appears more sensitive than the TST in HIV 
infected individuals, but this sensitivity appears impaired in those with severe immuno-
suppression.”29 
 
Lab Diagnosis : 
Research in new diagnostics, treatment and prophylaxis for tuberculosis is happening in a fast 
pace. The global plan to stop TB formulated a plan to make these new modalities available to 
resource less countries and high TB prevalent areas. This organization involved in the adoption, 
introduction and implemention of these new techniques. 
In study by harries AD in 2001 “Up to 20% of all the TB patients in sub Saharan Africa, whom 
the treatment is initiated die within a year and 2/3 rd of these deaths occur in first 2 months”.30 
Isn’t this pathetic? This study reveals that the delay in detection of TB due to inadequate 
diagnostic techniques resulting in patients presenting in advanced stage of the disease. 
In a study by Pai M on novel and improved technologies for tuberculosis diagnosis in the 
journal of clinical chest medicine states that “the WHO stop TB partnership's new diagnostics 
working group and foundation for innovative new diagnostics (FIND) have classified tools for 
the diagnosis of TB as the following: 
1) WHO endorsed Tools 
2) tools in late stage development or evaluation 
3) tools in early stage development.”31 
in a study by lange C et al and pai M et al states that “considerable effort and resources have 
been invested in developing novel diagnostics and improving existing ones”.32,31 
In studies by madebo T et al &liam CK et al “patients in many countries with high TB burden 
do not receive diagnosis for 3-6 months”.33,34 
the world health organization said “although the treatment success rates are improving every 
year, case detection rates are increasing more slowly”. 
In the journal of clinical microbiology review linda M parsons et al states “the global 
awakening to TB's devastating impact on vulnerable populations has been brought about in 
many countries by its deadly synergy with HIV. In response WHO has provided several key 
guidance documents for national TB control and laboratory programs for the use of LED 
microscopes to improve the sensitivity of a turnaround time of front line assay, sputum smear 
microscopy, and for improving the accuracy of TB detection and drug susceptibility testing 
through the use of liquid culture and molecular line probe assays”26 
In a study by madhukar pai in the new tools and emerging technologies for diagnosis of 
tuberculosis states that “despite this enormous burden (high prevalence of TB) case detection 
rates are low posing major hurdles for TB control”.31 
In the African continent alone, less than 50% of cases are being detected by the currently 
adopted DOTS programmes. There are new challenges to this  like drug resistance and HIV co 
infection. 
In studies by perkins MD et al & WHO global tuberculosis control report 2010 states that “the 
dual specters of TB and AIDS have drawn recent attention to the lack of suitable diagnosis for 
TB”35 
In study by study by Keeler E et al on reducing the global burden of tuberculosis states that 
“TB case detection is the first hurdle towards tackling the TB epidemic”.36 
In studies by abe C et al, beavis et al, down et al states that “to address the need for rapid and 
sensitive identification of Mycobacterium tuberculosis and other mycobacteria, various 
genotyping methods for routine diagnosis have been introduced during the past decade”.37,38,39 
In a study by fisher M on diagnosis of MDR TB states that 
“Theres a long standing need for new, rapid, accurate and convenient tests for TB diagnosis and 
drug resistance is currently being addressed by several agencies and group”40 
In a study by perkins et al in the topic admitting defeat in a journal states that “conventional 
tests for detecting drug resistance are slow, complicated, expensive and difficult to perform in 
field conditions”35 
in a study by Moore DF et al & campos M et al states that “a highly sensitive rule in test can 
significantly improve the case detection whereas a highly specific rule out test can reduce the 
turnaround time and the duration of respiratory isolation as well as unnecessary administration 
of potentially toxic drugs”.41,42 
In a study by lemaire J et al on advances in the diagnosis of tuberculosis states “despite the 
recent advances in TB diagnosis, cost and accessibility continue to be the major limiting factors 
in the effort to eradicated tuberculosis”.43 
In a study by catharina C.Boehme et al states that “improved technologies that can abbreviate 
the diagnostic process and facilitate early diagnosis can save patients time and money, decrease 
morbidity, improve treatment outcomes, and interrupt the transmission of the disease”.44 
In a study by perkins in the international journal of tuberculosis and lung diseases states that “ 
such technologies need to be more sensitive, faster in yielding results and simpler to use than 
microscopy”35 
in a study by Pai M et al in the national medical journal of india states “better efforts to control 
TB require faster and more accurate diagnostic tests”.31 
According to WHO any new technique for diagnosing TB should have the following things to 
be considered: 
 should be evidence based. Not only should the test be effective in controlled trials but 
also should perform well in actual field conditions 
 the program readiness: the implementation of any technique requires change in national 
policy and treatment guidelines. 
 Turnaround time: results should be faster than existing ones 
 cost effective 
 quality control measures strictly adhered 
 biosafety precautions adopted 
 adequate staff training 
The currently available diagnostic techniques at a glance 
1) Sputum microscopy: its 125 years old technique and remains the most common method used 
in the diagnosis of TB. 
In a study by geojith george et al states that “notwithstanding the advent of novel diagnostic 
techniques ,smear microscopy remains the most practical test available in resource limited 
settings, where majority of the TB is present”.45 
Its rapid and requires little training to the technicians and no bio safety levels are required. 
In a study by steingart KR on fluorescence vs conventional sputum smear microscopy for TB 
states that “microscopy is rapid, specific and inexpensive but has low sensitivity”46 
it depends on the bacterial load in the specimens and detects around 50% of all active cases. 
sensitivity is very low (20%) in children and HIV patients. The cons include inability to detect 
resistance to drugs. 
In a study by mathew P et al in journal of clinical microbiology and expert review of molecular 
diagnostics 2010 states that “while cheap and relatively easy to perform, the more than 125 
year old smear microscopy method has only modest sensitivity (35-80%) and cannot 
differentiate between drug sensitive and drug resistant Mycobacterium tuberculosis”47 
In a study by dye et al on evolution of TB control and prospects of reducing TB incidence 
report “the human immunodeficiency virus epidemic has further diminished the utility of 
routine microscopy and smear negative TB has arisen as a particular problem in sub Saharan 
Africa”.48 
The patient has to come twice to the clinic. Once to give the specimen and second to collect the 
results. This means the transportation costs and the loss of pay. 
In studies by foulds J et al in the new tools for diagnosis of tuberculosis and perkins MD et al 
in international journal of tuberculosis and lung diseases the limitations of conventional 
methods of diagnosis including smear microscopy have been explained.49&35 
In parsons et al on clinical microbiology reviews states “in high incidence countries, TB control 
relies on passive case finding among individuals self presenting to healthcare facilities, 
followed by either diagnosis based on clinical symptoms or lab diagnosis using sputum smear 
microscopy. Serial sputum specimens are required which means that the people are asked to 
make repeated visits to the health care center for specimen delivery and collection results. For 
many patients, the costs of repeated visits to health care facilities are prohibitive and patient 
dropout is a significant problem”26 
in a study by squire sb et al in 2005 “in places where HIV is prevalent, the proportion of cases 
detected by smear microscopy is 20-30%.to address this issue multiple sputum examinations 
was done due to which a relatively large number of patients do not complete the testing”.50 
in a study by steingart et al published in lancet “sensitivity of sputum smear microscopy has 
been reported to vary from 20-80% often depending on the diligence with which specimens are 
collected ,smears are made and stained smears are examined”.46 
In a study by getahun et al published in lancet states “Tb smear microscopy is highly 
insensitive for HIV co infected individuals and for children due to the reduced pulmonary 
bacillary loads in these patients”.51 
In study by harries ad et al in 2003 “more than a third of patients with smear negative TB in 
Malawi needed more than 6 visits to a health care center for treatment to be initiated”52 
this is due to the difficulties in confirming smear negative TB, underlines the need the new and 
simple, yet rapid and effective diagnostic methods to address such cases. 
In parsons et al clinical microbiology reviews states “in resource poor countries many smear 
microscopy labs are single room and insufficiently staffed with poor maintenance of 
microscopes. These labs don’t have consistent clean water supply and electricity. There are few 
opportunities for the training of staff and little staff capacity to handle high volume workloads. 
Quality assurance programs including quality control and external quality assessments are often 
lacking. This a critical need for new, sensitive, easy and paid point to care diagnostics and also 










study by monkongdee et al states “the who recommendation is two rather than three sputum 
examinations be used was generated largely for non -HIV patients. However this approach was 
evaluated in HIV infected patients in southeast Asia and the incremental yield of microscopy 
was found to rapidly diminish to 2% after the second smear.53 
According to who laboratory policy in 2007 “for TB detection two sputum smear are to be 
collected and examined”. 
The above policy was drafted based on a meta analysis of 37 studies which quanitified the 
incremental yields of serial sputum specimens. 
In a study by mase at al in 2007 states “85.8% of Tb cases were detected with the first sputum 
specimen. With second sputum specimen, the average incremental yield was 11.9%, while the 
incremental yield of third specimen, when the first two were negative was 3.1%”54 
in a study by bonnet et al in 2007 conducted in Kenya shows “decreasing the number of smears 
examined for detection of TB leads to reduction of patient visits to clinic and lab workload”.55 
It is to be mentioned that the above reasons are major drawbacks of multiple smear 
examinations and prevent patient from taking from collecting the results thereby diagnosing 
TB. 
In a study by aziz et al tells “screening of TB patients from three to two specimens should be 
recommended only in settings with a well established lab network and a fully functional EQA 
program for smear microscopy including on site evaluation and follow up training for problem 
laboratories”.56 
Its a well known phenomenon that most of the labs in our country don’t have quality control 
assessments. 
In a report by world health organization-strategic and technical advisory group for Tuberculosis 
(STAG-TB) dated 2009 recommends “conventional fluorescence microscopy be replaced by 
LED microscopy in a phased manner.” 
 
in a study by steingarta kr et al “a meta analytical study of 45 studies show that the sensitivity 
advantage of fluorescence microscopy over conventional microscopy is greater by 10%”.46 
also sputum processing increases the chance of finding TB bacilli my microscopy by 13-33%. 
Tb Culture: 
It is the gold standard test. Most sensitive method and accommodates DST and speciation. 
Takes about 2-8 weeks since the TB bacilli is a slow growing organism having a slow 











WHO STOP TB report 2008 “some national TB programmes in developing countries have no 
functioning TB culture facility at all. In others its done only in national reference labs and high 
grade hospitals. Few countries have the capacity for DST”. 
Because of the shortcomings, automated liquid systems have been developed. 
In a study by william -bouyer n et al “these systems detect the O2 production, CO2 
consumption by radiometry, calorimtery, pressure sensors and decrease the time to detection by 
half”.57 
Disadvantage if this system includes contamination especially when inexperienced and difficult 
to examine the colony morphology. 
In a study by van kampen sc “the liquid culture systems suffer from important shortcomings as 
they are prone to contamination, human resource intensive, costly”.58 
 
In studies by kocagoz t etal &baylan o et al “solid media called TK uses a colorimetric method 
to find the bacterial growth. Its possible to discriminate and differentiate non tuberculous 
bacteria in this method. Its cheap and rapid. Detection time is 10 days less than conventional LJ 
media”.59&60 
In study by farnia p et al “a number of redox reagents have been developed to find the bacterial 














MODS-microscopic observation drug susceptibility: 
manual technique in which the colonies of the culture are examined under a microscope, in this 
case an inverted microscope is used. 










Cons: the technique need training to technicians, bio safety level 2 precautions and difficulty in 
differentiating between NTM and MTB. 
In a study by Moore DA et al “by adding Anti TB antibiotics to adjacent wells and examining 
for comparative growth, MODS can be applied for early detection of DST as well”.62 
In a recent study on a large scale carried out in Peru by Moore DA et al “MODS detected 94% 
of 1908 culture positive cases whereas LJ medium detected only 87%”.62 
the average detection time in this method was only 8 days. 











Septi check AFB method: 
In the ICMR bulletin dated 2002 “it is non radiometric method has the unique advantage of 
simultaneous detection of MTB, NTM and contaminants”.63 
In a study done in USA by isenberg HD et al shows “the system gives a better culture result 

















Radiometric BACTEC 460 TB method: 
14C labeled palmitic acid in 7H12 medium is used. When MTB grows 14C is generated which 
is measure by the system. The system also identifies MTB as well as can be used for DST. 
In a study done in TRC, chennai by Venkatraman Et al shows “rate of isolation of positive 
cultures was significantly faster with the BACTEC method with 87% of the positives obtained 











MGIT 960 mycobacteria detection method: 
In this method, O2 utilization by MTB is determined by a fluorescent dye in the medium. Its an 
automated system. 
In a study 
carried out in 
usa by tortoli 
et al “this 
system 






 MB/Bact system: 
Its a non radiometric methods based on the colorimetric detection of Co2. 
In a study by rohner et al concludes “this systems is a good alternative to BACTEC 460 despite 














ESP culture system 2: 
automated system based on the detection of pressure changes in the media in a study by woods 
et al “ its a reliable, less labour alternative to BACTEC , however it should not be used as a 






Phage based test: 
underlying principle: the ability of phages to infect bacteria has been used. 
A lytic mycobacteriophage D29 infects the TB bacilli and killed with a virucide.this procedure 
only kills the virus and not the bacteria inside, later the cells are plated on a lawn of 
Mycobacterium smegmatis producing plaques indicating the disease(TB). The test could be 
done in days. 
In  studies  by albay a et al, butt t et al “this test detects 29%-87% of smear positive cases and 
13-78% of smear negative cases in 2 days”.69,70 
In a study by alcaide F et al “the capacity of D29 phage to replicate in nontuberculous 
mycobacteria has not impaired clinical specificity which remained high (99.1%) even in a 
study in which 30% of all culture isolates were non tuberculous mycobacteria.71 
This technique requires necessary infrastructure . 
Immunodiagnosis 
In studies by gennaro ML et al, daniel TM et al ,bothamley GH et al, “immune based tests for 
detection of antigen, antibody and immune complexed have been reviewed”.70,71,72 
There's no such test available yet to replace smear microscopy and culture. 
The problem is these test aim at detecting the humoral response rather than the cell mediated 
immunity which plays a prominent role in TB. 
The above mentioned studies have analyzed the reason for failure of such tests. 
In studies by Laal S et al “the Tb is characterized by a wide spectrum from latent to active and 
in each stage different set of antigens are expressed, and even in a single stage the antigens are 
not the same, for eg: its different from cavitary lesions and the disease with non cavitary 
lesion”73 
Hence any serological test should encompass to detect all these antigenic responses. Previously 
crude antigens were used, which led to poor specificity. 
In review by Madhukar Pai et al “the development of recombinant proteins specific to MTB 
has partially overcome this problem”.74 
Many serological tests employ a single antigen and hence the detection of disease during all 
stages is less. In the above mentioned studies “the development of a cocktail of antigens 
specific to each stage of the disease has partially addressed this problem”. 
Lipoarabinomannan assay: 
Its a heat stable glycolipid present in the cell wall of mycobacteria. 
Instead of searching for an antibody response specific to an antigen, this test aims at finding the 
specific antigen using a capture ELISA method 
This method has demonstrated some success. Further evaluation needed. 
Interferon gamma release assays (IGRAs): 
Its a diagnostic immune response Tb test. The standard Mantoux or tuberculin sensitivity test 
has many limitations. This new tests measures the cell mediated immunity in response to MTB 
specific antigens which are not present in BCG and NTM there by specific to MTB. Two tests 
are currently available. The quantiferon TB gold test and the T spot TB test. The best thing is 
prior BCG vaccination does not give a positive test, thereby useful in screening. 
This test is not without limitations. There's no evidence to find which case with progress to 















MPB64 skin patch test: 
MPB 64 is a Mtb specific protein. 
In research by Nakamura et al in japan in 1998 “the test was capable of eliciting a distinct 
response from individuals with active but not latent TB , the sensitivity was 98% and 
specificity was 100%”.75 








also it could be used in lateral flow assays in differentiating Mtb from NTM 





Nucleic acid amplification tests(NAT) are designed to 
amplify regions specific to MTB complex. They are available as commercial kits. In USA 
amplicor and MTD are FDA approved. 
In studies by Piersimoni C et al & Hugget Jf et al “the 3 widely used methods are PCR, 
transcription mediated amplification(TMA) and strand displacement amplification. These 
methods show excellent speed and specificity, sensitivity approaching but not equaling 
culture”.76,77 
In house NAT are predominantly used in research settings. 
In studies by Brodie et al, Pai M et al “the literature of NAT has been extensively reviewed” 
In meta analytical studies by Flores L et al, Pai M et al “the results demonstrate that AT have 
high specificity for both pulmonary and extra pulmonary TB”.78&31 
In review by Madhukar Pai et al in the journal of expert review on molecular diagnosis “high 
specificity and positive predictive value confer clear advantages in terms of the tests ability to 
rule in TB. A positive NAT in a patient with a high pretest probability is fairly confirmatory of 
TB, particularly in smear positive cases”.79 
It also says “the sensitivity of NAT is lower and highly variable across studies. In many studies, 
sensitivity estimates have been lower in paucibacillary forms of TB. Therefore a negative test 
does not rule out TB”. 
A negative NAAT with a positive smear can be non tuberculous mycobacteria. 
Disadvantages: Cannot differentiate between live and dead bacilli as the DNA can be amplified 
in both cases. 
In a meta analytical study by Flores et al on the accuracy of in house PCR tests “the use of 
IS6110 as an amplification target and the use of nested PCR were associated with higher 
accuracy”79 
in the ICMR bulletin dated august 2002 “IS6110 is specific for MTB and is present upto 20 
times in its genome, thus offering multiple targets for amplification”.63 
the author Madhukar Pai et al in this review concludes that “in general, the concerns about 
accuracy, reliability and requirement for necessary infrastructure reduce their applicability in 
resource limited settings”.74 
In a study by Suffys P “even in established molecular labs, the performance of NAT is highly 
variable, implying the need for more robustness”.80 
One such promising technology is the LAMP, loop mediated isothermal amplification. It was 
invented by Eiken chemicals, japan. 
In study by Iwamoto T et al “the advantages of this technology is that it uses 6 specifically 
designed primers and a single polymerase with strand displacement activity, requires no 
thermocycler, its a closed system needing no bio safety levels and gives a visual readout by 
naked eye”.81 
In study by Boehme C et al “preliminary data suggests that this test can be done in a benchtop 
by technicians with no molecular training detecting all smear positive specimens and half of the 
smear negative specimens”.82 
The inventor Eiken in its website claims that “the amplification efficiency is high and DNA can 
















 Gene x pert: 
This test detects both MTB and rifampicin resistance. This is a hemi nested PCR 
In a study by Helb D, Blakemore R “in this test PCR amplification of five overlapping probes 
that are complementary to the entire 81 base pair RIF resistance determining region of the 
MTB rpo B gene and subsequently probes this region for mutations that are associated with 
Rifampicin resistance”. 
Disadvantages include high cost. In a review by Mark D Perkins et al “FIND(foundation for 
innovative and new technologies) is working with cepheid to develop a real time PCR assay for 
TB on its gene xpert platform that automates sputum processing, DNA extraction, gene 
amplification and target detection into a single, hands free test”.35 
Line probe assays : 
in review by Madhukar Pai et al says “line probe assays are are strip based tests that use PCR 
and reverse hybridization methods for the rapid detection of mutations associated with drug 
resistance and detection of MTB complex”.74 
 
In a meta analytical study Morgan et al “the line probe assay has high sensitivity and specificity 
when culture isolates are used, less when directly applied on clinical specimens”84 
These tests are expensive and need sophisticated labs. 
Materials and methodology: 
This is a comparative evaluation of three techniques , fluorescence microscopy ,culture using 
solid media and LAMP PCR. 
This study is done in tirunelveli medical college hospital over a period of four months from 
june 2015 to september 2015 
Sample selection: 50 samples randomly collected from the district tuberculosis centre, from 
patients suspected of tuberculosis as referred by expert thoracic physicians in the department of 
thoracic medicine. 
1) Fluorescence microscopy: 
Principle: 
Mycobacteria are acid fast.ie., they resist decolorizing even after exposure to acid. In this 
technique carbol fuschin is replaced with auromine -O. The mycolic acid in the cell wall has an 
affinity for fluorochromes. The counter stain to differentiate the background is potassium 
permanganate. The advantage is greater area can be examined under low power microscope 
thereby enabling a larger area to be examined in a less time. 
The mycobacteria appear as yellow luminous rods. 
Sputum smear preparation: 
Label a new clean slide 
using a 5mm nichrome sterile loop transfer sputum to the slide 
smear the slide for an area of 2-3 cm 
air dry for 15 minutes 
heat fix by passing over the flame 3-4 times 













































The procedure was followed as per TBC India guidelines. 
The following reagents were required 
1) 3% phenol: 
2) Auramine-phenol solution 
3) acid alcohol 
auramine-phenol preparation: 
3% phenol 100 ml was warmed to 40ºC 
0.3 gm of auramine was added and shaked for 10 minutes 
The solution was filtered using whatman No.1 filter paper and stored in a dark glass bottle. 
Acid Alcohol preparation 
0.5 ml HCL 
0.5 gm NaCl 
75 ml absolute alcohol 
25 ml distilled H20 
4)0.1% KMnO4 
2) Culture In Lowen Stein Jenson Media: 
mucoid or mucopurulent sputum for cases suspected of pulmonary tuberculosis was collected 
from the district TB center, department of thoracic medicine, tirunelveli. 
the specimen was labeled and the laboratory number of each specimen noted. 
Strict bio safety precautions were used. N95 mask and gloves were used for sputum handling. 
The specimens were decontaminated by modified petroff's method as per TBC guidelines. 
 
Specimen should be processed as described below: 
 1.5 ml of sputum in universal container is transferred to centrifuge tube and double the volume 
of NaOH 4% is added 
↓ 
2. the tubes are inverted and the sputum is mixed well. 
↓ 
3. the tubes are kept in votex shaker for a minute and then in incubator at 37ºC for 15 minutes 
↓ 
4.after 20 minutes, 15 ml of distilled water is added to the tubes 
↓ 
5.  centrifuged at 3000 x g for 15 minutes. 
↓ 
6.supernatant fluid discorded in a disinfectant solution( bleach solution) 
↓ 
7. another 15 ml distiller water added and centrifuged at 3000 x g for 15 minutes and the 
supernatant discarded. 
↓ 
8.the pellet is inoculated in 2 slopes of LJ media. 
 
Growth is checked weekly for 8 weeks. 
 
 
Reading Of Cultures: 
the colonies of Mycobacterium tuberculosis appear as rough, buff, like bread crumbs and 
appear 2- weeks after incubation 
If the colony has doubtful morphology then Ziehl Neelson staining is done.if no afb is seen 
then the culture is discarded as contamination. 
If smear positive then the following biochemical tests were done 
1) Niacin 
2) Nitrate 
if both were positive ,then Mycobacterium tuberculosis was confirmed 
if niacin is negative then depending on the pigmentation and morphology they were grouped 
under BCG or M.bovis and non tuberculous mycobacteria. 
 
Flow chart depicting the identification of tubercle bacilli based on growth on LJ medium 
 























the findings were reported as per below 
Reading of culture report 
No growth Negative 
1-100 colonies positive(number of colonies) 
>100 discrete colonies Positive 2+ 
Confluent growth Positive 3+ 
contaminated contaminated 
<20 colonies of only NTM is one or both 
slopes 
No growth 
>20 colonies of only NTM in both slopes Negative for M.Tb 
 
media was prepared as per annexure 1 attached 













biosafety cabinet for sputum processing and 
inoculation 
 
 3) LAMP PCR: 
DNA purification procedure: 
1) from the pellet prepared by homogenisation and decontamination after inoculation into the 
LJ slopes the remainingis used. 
2) add 180μl of digestion buffer and 20μl of lysozyme .votex for 10 seconds 
3)incubated at 37ºC for 15 minutes 
4)200μl of binding buffer and 20μl of proteinase K added.mixed well using votex 
5)incubated at 56º C for 15 minutes 
6) 300μl of ethanol added and mixed well by inverting several times. 
7)pipette entire sample into the spincolumn.centrifuged at 10000 rpm for 1 minutes. Discard 
the flow through and place the column back into the same collection tube. 
8) 500μl of wash buffer-1 added to the spin column.centrifuged at 12000 rpm for I minute and 
the flow through discarded.place the column back into the same collection tube. 
9)add 500μl of wash buffer-2 to the spin column .centrifuged at 12000 rpm for 1 minutes and 
the supernatant discarded.the column is placed back into the same collection tube. 
10)repeat wash buffer-2 wash once 
11) centrifuge the spin column with collection tube at 13000 rpm for 1 minute 
12) discard collection tube and transfer the spin column into a fresh 1.5 ml fresh micro 
centrifuge tube. 
13) add 100μl of prewarmed elution buffer to the centre of the spin column membrane 
14)incubate for 2 min at room temperature and centrifuge at 13000 rpm for 1 minute.discard 
the spin column and store the purified DNA at -20ºC . 
Materials required: 
pure fast bacteria; DNA mini spin purification, isothermal master mix, SYBR green Dye and 
primers are from helini biomolecules 
isothermal master mix contains: reaction buffer, 1.6mM of dNTP mix, 0.5 M of betaine,6mM 
of MgSO4,8U of Bst DNA polymerase 



























Loop Isothermal Master Mix 10μl 
Primer Mix 5μl 
Purified DNA 5μl 
Final volume 20μl 
 
Negative control and Positive control are included in every run. 
Centrifuged and incubated at 65°C for 1hour. 
Visualization 
1μl of 10X SYBR Green dye added to each PCR tube and gently mixed by vortex and placed 
over UV transilluminator and illumination are compared with Negative control and 
interpreted. 




























in the present study 18% of the study population was below the age of 30, 18% between 31-40, 
another 18% between 41-50, 24% of the cases were between 51-60 and 22% of the cases were 















































































































































































































when compared with the gold standard “culture in solid media” the smear microscopy using 
LED fluorescence showed sensitivity of 62% and specificity of 48% 
positive predictive value was 46% 
negative predictive value was 64% 
p value in McNemar test is 0.21 
kappa agreement is 9.72% 











table 9-sensitivity and specificity of PCR: 
 
 
Statistic Formula Value 95% CI 
Sensitivity 
 
95.24% 76.18% to 99.88% 
Specificity 
 
79.31 % 60.28% to 92.01% 
Positive Likelihood 
Ratio  
4.60 2.24 to 9.45 
Negative Likelihood 
Ratio  
0.06 0.01 to 0.41 
Disease prevalence 
 




76.92% (*) 56.35% to 91.03% 
Negative Predictive 
Value  





the sensitivity of the LAMP PCR was 95.24% , specificity being 79.31% with a confidence 
interval of 95% 
positive predictive value was 76.92% 
negative predictive value being 95.83% 
McNemar test P value :0.125 
cohen's kappa :72% 
kappa agreement P value:<0.0001 
















as tuberculosis is one of major causes of death and is preventable if taken appropriate 
measures.the foremost is detecting the disease in an early stage and initiating treatment thereby 
preventing its spread.the earlier methods of “sanatorium” ,isolation have been proved 
inadequate when compared with antibacterial treatment in preventing the spread. 
In this study we compare LAMP PCR & fluoresce microscopy with culture using Lowenstein 
Jenson media in 50 clinical specimens(sputum) collected from cases suspected of tuberculosis 
for the diagnosis of Mycobacterium tuberculosis. 
The specimens were collected from the district tuberculosis center, tirunelveli by informed 
consent to the patients. 
the ethical committee clearance from the ethical committee board, tirunelveli medical college 
was obtained. 
The suspicion criteria was based on the symptoms of cough with expectoration of more than 2 
weeks and decided by the thoracic physicians in the department. 
The laboratory diagnosis of tuberculosis chiefly relies on smear microscopy. The Ziehl Neelson 
method of acid fast staining is routinely carried out and the RNTCP has phased the 
fluorescence microscopy as an alternative method whereby the time to examine more fields can 
be reductionis is because the low magnification used to examine the fields, thereby examining 
more fields in a single sitting. The time consumed by fluorescence microscopy to examine 100 
fields is 2 minutes by experienced personnel. 
However the technique has limitations in that its sensitivity and specificity are less and 
identification of species is restricted which makes the need for a better technique with same 
robustness, speed, cost effective with no additional expenses for manpower training and bio 
safety levels which can penetrate the rural and inaccessible areas of the TB endemic areas to 
find the TB bacilli and thereby initiating treatment. 
In a study by Mathew P et al in journal of clinical microbiology and expert review of molecular 
diagnostics 2010 states that “while cheap and relatively easy to perform, the more than 125 
year old smear microscopy method has only modest sensitivity (35-80%) and cannot 
differentiate between drug sensitive and drug resistant Mycobacterium tuberculosis”47 
in a study by Steingarta KR et al “a meta analytical study of 45 studies show that the sensitivity 
advantage of fluorescence microscopy over conventional microscopy is greater by 10%”.46 
The culture is a gold standard, useful in identification of species as well as high sensitivity and 
specificity, it has shortcomings in that it needs 8 weeks time. 
In this study we compare LAMP PCR & fluoresce microscopy with culture using Lowenstein 
Jenson media in 50 clinical specimens(sputum) collected from cases suspected of tuberculosis 
for the diagnosis of Mycobacterium tuberculosis. 
The specimens were collected from the district tuberculosis center, tirunelveli by informed 
consent to the patients. 
the ethical committee clearance from the ethical committee board, tirunelveli medical college 
was obtained. 
The suspicion criteria was based on the symptoms of cough with expectoration of more than 2 
weeks and decided by the thoracic physicians in the department. 
The specimens once collected were processed and stored at -20ºC for culture and PCR. 
Bio safety precautions were observed during handling of the specimens and processing. 
The test results were read during every week for 8 weeks before declaring negative if there was 
no growth at the end of 8 weeks. 
Specimens were used for culture &  PCR. 
The PCR test was performed with kit from helini biomolecules. 
DNA purification and PCR was done as per the manufacturers instructions. 
The sensitivity of the smear microscopy in this study is 62%.this is in accordance with earlier 
study by mathew P et al in which “the sensitivity of the smear microscopy is 30-80%”46 
it should also be noted that fluoresce microscopy improves the detection rate by another 10%. 
The 62% sensitivity rate of the smear microscopy in this study indicates better lab practices, 
experienced technicians and the high prevalence of TB in this area. 
In the study geojith et al says “Smear microscopy detects the morphology of the bacilli while 
culture methods differentiate based on the physiology of the organism”. 45 
LAMP detects the presence of DNA in the specimen whether live or dead the organism may 
be.these two techniques are complementary to each other in the sense LAMP detects the 
genetic material more when the smear and culture results are positive. 
In this study LAMP shows an excellent sensitivity of 95% which is in higher than earlier study 
by geojith et al in which the sensitivity was 79.5%  .earlier studies showed better specificity. 
This is in accordance with our study. 
in a study by Pal N sharma et al in the indian journal of pathology “78.65%  specimens were 
culture positive when processed within 48 h by the NaOH method. The culture positivity in the 
same specimen that were stored with cetylpyridinium chloride and processed after 7-8 days was 
70.22%, whereas those stored without CPC and processed by the NaOH method was 
46.62%”85. 
In a study by catherine Boehme et al “The sensitivity of LAMP in smear- and culture-positive 
sputum specimens was 97.7%  and the sensitivity in smear-negative, culture-positive specimens 
was 48.8%”.82 
the sensitivity of the above study is higher than the present study. 
In a meta analytical study by daphne I, madhukar pai et al “commercial NAAT techniques are 
highly variable , the sensitivity is inconsistent with the specificity. The study further holds that 
based on the observation its not recommended for NAAT to be replaced for the conventional 
tests in the present situation”.86 
It is to be mentioned that a study should have a higher sensitivity and specificity. It it has lower 
specificity then more persons who dont have disease are identified to have disease and further 
investigations are ordered or treatment started which is detrimental to patients health and 
unnecessary expenditure. 
According to WHO report on the use of nucleic acid amplification tests for the diagnosis it 
states that in one large study the sensitivity was only 53%. 
in a study by olga l et al on the Assessment by Meta-Analysis of PCR for Diagnosis of Smear-
Negative Pulmonary Tuberculosis 87 Sensitivity ranged from 9-100% while the specificity 
ranged from 25 to 100%. 
in a study by lydia kivihya et al on the Comparison of PCR with the Routine Procedure for 
Diagnosis of Tuberculosis in a Population with High Prevalences of Tuberculosis and Human 
Immunodeficiency Virus88 
“The sensitivity and specificity of PCR were 93 and 84%, respectively. HIV status did not 
affect the sensitivity of PCR. A total of 99.7% of the true smear-positive and 82.1% of the true 
smear-negative TB patients were correctly identified by PCR. PCR detected M. tuberculosis in 
11.7% of the culture-negative suspects, 60% of which had one or two PCR-positive sputum 
specimens”. 
This indicates that the PCR technique can be applied to identify smear negative pulmonary 
tuberculosis   
in a study on application of loop mediated isothermal amplification (lamp) assay as an 
alternative diagnostic test for rapid tuberculosis diagnosis in limited resource setting 
Sensitivity of LAMP was 97.47% , the specificity being 60.31. the higher sensitivity means this 
test could be used as an alternative for smear microscopy in TB endemic countries like india 
for rapid and cost effective diagnosis. 
In a study by mitarai ,okumura et al on the evaluation of a simple loop-mediated isothermal 
amplification test kit for the diagnosis of tuberculosis 89 
: The sensitivity of LAMP using raw sputum in smear- and culture-positive specimens was 
98.2%  while the sensitivity in smear-negative, culture-positive specimens was 55.6% (95%CI 
43.4–68.0). 
the test says that the sensitivity of lamp was not lower than the commercial amplicor assays for 
tuberculosis. 
In  a study by basu dev pandey et al “Using this system, a total of 200 sputum samples from 
Nepalese patients were investigated. The sensitivity of MTB-LAMP in culture-positive samples 
was 100 % (96/96), and the specificity in culture-negative samples was 94.2 % (98/104, 95 % 
confidence interval 90.5–97.9 %). 90 
in the study by geojith G et al on the efficacy of LAMP in lab detection of MTB the sensitivity 
was 91.7% and specificity was 90.9% in 2 hour format.45 
In the present study the incubation time was 1 hour.increase in incubation time increases the 
sensitivity of the test as per the above mentioned study.The need for modification of protocols 
to give a better effficacy needs to researched in further studies. 
In a study by ehsan aryana et al “ the accuracy of the LAMP method was tested using 
restriction endonucleases enzymes to digest the byproducts of LAMP and then visualised using 
agarose gel electrophoresis”91 
this study confirms the accuracy of the LAMP reaction. 
Recently another study by lee et al 2009, 
One technique called reverse transciption loop mediated isothermal amplification combined 
with enzyme linked immunosorbent hybridisation (RT-LAMP-ELISA) was used to target the 
16S ribosomal RNA.the test detected one copy of 16S RNA per reaction .this is comparable 
with the IS6110 based MTB LAMP assay. This technique however is costly compared with 
LAMP MTB .92 
The cost of single LAMP reaction in our study is Rs.500-/-.whereas the technique mentioned 
above could cost upto 660/reaction. 
if both smear and PCR are positive in clinical specimens then the diagnosis of tuberculosis is 
assumed. 
However in studies by ru-yi zhua et al on the LAMP test correctly identified the MTB 
DNA(M.tuberculosis, M.bovis and BCG strains) & did not detect the non tuberculos 
mycobacteria and other bacteria. This shows the specificity of this test.92 
In the study by ehsan aryana et al shows  identical sensitivities were obtained for LAMP and 
nested PCR, but the LAMP assay was more rapid and cost-effective than the latter. 
















the present study aimed at detection of Mycobacterium tuberculosis in clinical specimens from 
patients suspected of tuberculosis with history of fever, cough with expectoration for 2 
weeks ,loss of weight, apettite and were referred for lab diagnosis of Mycobacterium 
tuberculosis by expert thoracic physicians from the department of thoracic medicine, tirunelveli 
medical college.all the sample were collected within a time of 2 months, decontaminated and 
homogenised by modified petroff's method using TBC guidelines.fluorescence microscopy was 
done on unprocessed samples and their results collected, however the test is a blinded study 
and the results were compared at the end of the study. 
The processed specimens were then inoculated in LJ media , freshly prepared using a 
standardized method and the rest of pellet was used to detect MTB by loop mediated isothermal 
amplification.the results were compared at the end of the study.the results of the study were 
analysed and summarised below 
 
 the age wise percentage of patients included in the study: 
18% of the study population was below the age of 30, 
18% between 31-40, 
 18% between 41-50, 
24% of the cases were between 51-60 and 
22% of the cases were more than 61 years of age. 
50 samples were randomly selected from the regional tuberculosis center of which 
 22% of the study population were females and the rest 78% were males. 
culture was positive in 42% of the subjects and negative in 58%. 
graph 4 shows PCR was positive in 52% of the study population and negative in 48% cases. 
Graph 5 shows fluorescence microscopy was positive in 56% of the subjects were as negative 
in the rest 44%. 
false negative was seen in one sample. which may be due to contamination. 
False positive was seen in 6 samples 
true positive in 20 samples& 
true negatives in 23 samples. 
fluoresence microscopy using auromine staining when compared with the gold standard 
“culture in solid media” shows 
sensitivity of 62% 
specificity of 48% 
positive predictive value was 46%, 
negative predictive value was 64%, 
P value in McNemar test is 0.21, 
kappa agreement is 9.72%, 
P value for kappa agreement is 0.474. 
comparison of LAMP PCR with gold standard technique which is culture in solid LJ media 
shows 
sensitivity of the LAMP PCR was 95.24%, 
specificity being 79.31%, 
positive predictive value was 77%, 
negative predictive value being 96% 
P value for Mcnemar test  0.125 
P value for kappa agreement was <0.0001, 
kappa agreement was 72% 
HIV infected samples were too low and hence were neglected for consideration 
also there was no relevance in the positivity rate for male and female patients 
age wise distribution of the samples did not bear any specific outcome for the study. 


















LAMP PCR can be used for detection of mycobacterium tuberculosis comples in sputum 
samples with a high degree of sensitivity and moderate levels of specificity. 
In culture and smear analagous samples the sensitivity is higher. 
the important advantage of LAMP is its robustness, speed in detecting the organism.the 
detection time is one hour and needs little training to be done 
However whether its an active or latent infection needs clinical findings and other assays like 
Interferon gamma release assays. 
When used in conjunction with smear microscopy the results are good. 
a large study and subsequent research is required for its implementation as an accepted 
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Preparation of culture media: 
Ingredients: 
Mineral salt solution with malachite green: 
 potassium dihydrogen phosphate-2.4 g 
 magnesium sulphate -0.24 g 
 magnesium citrate-0.6 g 
 asparagine-3.6 g 
 glycerol-12 ml 
 malachite green 2% solution-20 ml 
the above components are dissolved in 600 ml of distilled water and autoclaved at 121º C for 
15 minutes and then cooled at room temperature. 
Homogenised whole eggs: 
 the eggs are scrubbed with soap and water 
 soaked in soap water for 30 minutes 
 rinsed 
 soaked in 70% ethanol for 15 minutes 
 eggs cracked into a sterile glass beaker 
 using an electrical blender , blended for 1 minute 
for 600 ml of mineral salt solution 1 litre of homogenised whole eggs are added and 8 ml are 
injected into sterile autoclaved Mcartney bottles .the bottles are then screw capped. 
the inspissator is heated to 85ºC ,the bottles are put in a slanting position and the media allowed 
to coagulate for 50 minutes. 
Later the bottles were kept in a refrigerator for inoculation . 




























date of sputum collection 
reason for examination: 
a) diagnosis 






























Tuberculosis is disease known since ancient times. The earliest discovery 
dates back to 6000 years ago among the human remains in Egypt1. It was also 
isolated from the mummies around 2400-3000 B.C. It’s also a disease which has 
defied the scientific achievements and miraculous cure for so many diseases that 
modern medicine was able to do in last century. The immunology and 
understanding of infectious diseases started with the identification of bacteria 
under a microscope by Anton Van Leuwenhoek in the 16th century. It’s to be noted 
that earlier systems of medicine such as the Greek, Persian medicine though 
formulated that certain diseases are contagious and are transmitted by “invisible 
particles”, the modern medicine or the western medical system proved a 
breakthrough in making these “invisible particles” as visible. 
Since Koch's discovery of the TB bacilli in 1882, microscopic detection of 
the bacilli in clinical specimens has remained as the cornerstone of TB diagnosis 
in low and middle income countries. 
Many of us would know that the killer diseases of ancient times such as 
anthrax, plague, small pox were almost eradicated from the face of the earth by 
the deeper understanding of science, how our body reacts to foreign agents, and 
the discovery of penicillin and so on. Only a few infectious diseases still exist 
which defies the human developments...it would not be an exaggeration to say that 
though effective treatments, diagnostic methods had been evolved to tackle 
tuberculosis it is still largely “invisible” or undetected. 
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The statistics by the world health organization says that one third of every 
human being in this world is infected with Mycobacterium tuberculosis 3, 4. Not to 
say it’s more prevalent in developing countries or the “third world countries”. This 
disparity in its geographical distribution is due to the poor living conditions, 
inadequate housing, poor sanitation, malnutrition and to a greater extent on the 
health care measures taken by the respective governments. 
India is one of world's nest in tuberculosis an estimated 2 patients per 
second die of tuberculosis5. And the post independent India started its national 
tuberculosis program since 1962 which was evolved in to the revised national 
tuberculosis control program in 1992 with the help of international agencies and 
adopted the international strategy of DOTS-direct observed short term treatment 
strategy5. 
The importance of tuberculosis and the need for further research into it is 
obligated by its “invisible nature”. Why it is said as “invisible”? Because the 
difficulties in the diagnosis whether clinical or non-clinical. In clinical spectrum 
the diagnosis includes symptoms such as cough with expectoration for more than 
2 weeks, evening rise in temperature, night sweats, loss of weight and appetite and 
radiologically in finding any cavity lesions in the lungs. In microbiology the 
diagnosis includes the classical acid fast staining method, the gold standard culture 
on solid media. The developments in molecular biology and the development of 
polymerase chain reaction has made numerous strides in the field of microbiology 
in diagnosing infectious diseases. Scientists have gone to the extent of describing 
the era of molecular biology as “before PCR” and “after PCR”. 
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The PCR techniques enables to diagnose small quantities of the infectious 
material and has proved to be a good diagnostic method in terms of sensitivity, 
specificity and rapidness. However they are not without negatives. The negatives 
include its cost, and cannot differentiate between live or dead organisms. 
The PCR technique originally developed by Gary Mullis in 1983 was based 
on amplifying a single gene or a few gene to many fold times, thereby enabling to 
identify them. He used a polymerase enzyme taq polymerase isolated from the 
thermophilic bacterium thermus aquaticus. In fact the process is named after that 
enzyme. Since then the process has been used in a wide variety of applications 
such as gene cloning, DNA fingerprinting and to identify infectious organisms. 
The method relies on the thermal cycling and enzymatic replication of the DNA. 
Primers which are short DNA fragments which are complementary to the target 
gene along with the polymerase enzyme make this possible. 
It is to be noted that PCR is not without errors, the polymerase enzyme can 
mutate the PCR fragments made and hence affect their specificity. 
The technique has been evolved into many variations and one of the 
variations is loop mediated isothermal amplification. This LAMP technique 
employs a Bst polymerase extracted from bacillus stearothermophilus. In contrast 
to the conventional PCR which uses thermocycling, this technique could be done 
in a constant temperature. This is made possible by using a polymerase enzyme 
with a high strand displacement activity in addition to the replication activity. 
Typically 4 different sets of primers are used to amplify six different areas of the 
target gene which adds to their specificity. A large number of copies are made and 
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their diagnosis is done with naked eye due to the increased precipitation of 
magnesium pyrophosphate which is a byproduct of the amplification. It can also 
be detected via photometry .dyes such as a SYBR green can be used to intercalate 
the amplified DNA and hence by measuring the color change it’s possible to 
quantitate the reaction as well. 
By eliminating the use of costly thermocyclers this technique promises a 
great and low cost alternative in diagnosing infectious diseases. The laboratory 
diagnostic method include Ziehl-Neelson acid fast staining which is routinely used 
in all the primary health care centers in India. However the sensitivity of the test 
is only 30%, thereby missing a huge chunk of the positive patients. Culture on the 
other hand is the “gold standard” but it needs sophisticated centers with biosafety 
levels and the result cannot be achieved unless 8 weeks which is huge time for 
which the treatment cannot be delayed. The skin test can determine the immune 
status of the individual and cannot determine if he's suffering from active diseases 
or had previous immunization, nevertheless it’s useful in screening purposes. The 
RNTCP has achieved great lengths in combating tuberculosis in India, 
nevertheless the gaps in diagnosing the infection still remains a hurdle. 
In India 40% of population are infected with tuberculosis with a lifetime 
risk of 100% even in the absence of HIV. The emergence of HIV has made the 
TB/HIV a dreadful combination as HIV itself is not a killer disease while it lowers 
the immunity, thereby making tuberculosis an opportunistic infection and thus the 
rates of Tuberculosis in patients infected with HIV has soared. One more thing 
which is of great concern is the emergence of the “super bugs”, which is the 
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multidrug resistance Tuberculosis which has higher mortality and morbidity. The 
RNTCP has launched PCR based techniques in detecting the above two clauses 
which is CBNAAT which is cartridge based nucleic acid amplification techniques. 
This has been accepted worldwide to detect Mycobacterium tuberculosis. But their 
role in screening Mycobacterium tuberculosis and detecting it in patients in 
outpatient setting has seen limitations owing to the higher costs and still needs 
further evaluation and research regarding the same. The present study aims to find 
the efficacy of this newer technique the “loop mediated isothermal amplification” 
in the detection of Mycobacterium tuberculosis in clinical specimens. As 
tuberculosis remains as one of the diseases which needs a definitive control 
strategy numerous research works are on the way especially in the light of MDR 












Aims and objective: 
 To find a low cost, rapid and efficient microbiological diagnostic 
method for the detection of Mycobacterium tuberculosis from 
clinical specimens that could be implemented without much training 
and even in a rural setting 
 To evaluate the sensitivity, specificity of loop mediated isothermal 
amplification in sputum samples collected from both smear positive, 
smear negative specimens in a blinded study and compare it with a 

















REVIEW OF LITERATURE: 
Epidemiology: 
According to ICMR bulletin dated august 2002, about one third of the 
world’s population is infected with tuberculosis. 
Around 10 million people acquire tuberculosis annually and 3 million 
people die of the disease each year. Mortality for tuberculosis is 25% of all 
avoidable deaths. 95% of all TB cases and 98% of death due to TB are in 
developing countries which includes India, and among them 75% are in 
economically active age group. 
In India around 2 million people acquire the disease annually and of that 1 
million people die of it each year. This means one patient dies of TB every minute. 
To compound this problem, is the emergence of HIV. 
India has 3.5 million HIV patients of which 1.8 million patients have TB. 
Around 60% of HIV patients acquire active TB during their life time7 . 
Its worth to mention the emergence of the super bugs MDR and XDR and 
their coincidence with HIV is nevertheless associated with higher fatality rates. 
Terminology: 
TB incidence: number of new cases of active TB /year 
TB prevalence: number of people living with active TB 






TB relapse: if the patient becomes ill after finishing the first course of 
treatments Treatment failure: some improvement or total failure to respond to 
treatment. 
Default: patients who havent finished the first course of treatments all the above 
three categories can develop drug resistance and need drug susceptibility testing. 
Exposure to TB depends upon the following factors: 
1) Number of active cases in a community 
2) Duration of their infection 
3) Number and nature of interaction between the active case and contacts 
in a given time. 
The above facts were derived from Tbfacts.org in a study by Dr.William W Stead 
in the annals of internal medicine say that “person who react after exposure of 
tuberculosis fall into three types.the reaction here is tuberculin sensitivity test. 
1) Patients who have positive TST and have a high risk of tuberculosis, they need 
prophylaxis 
2) Patients where there is no screening done before exposure and are positive to 
TST should be treated as like above said 
3) People who are positive to TST but the risk is too low..they dont need 
prophylaxis” 
Corresponding to the topic I am quoting another study which is worth when 
considering the screening in epidemics and health care workers8. 
In a study by Peter E Sokolovo in the annals of the internal medicine finds 
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that” systematic monitoring by tuberculin sensitivity testing is necessary to find 
the adequacy of respiratory isolation procedures carried out in the emergency 
department of a hospital during epidemics.” 
Smoking is a known risk factor which predisposes to tuberculosis.10 
In a study by Dr.C.Kolappan from the tuberculosis research center, ICMR 
published in british medical journal of thorax says that “ the association between 
tuberculosis and smoking is a strong dose-response relationship”.11 There's some 
good news.by implemeting effective diagnosis and treatment strategies a few 
countries have been able to bring down TB.eg: china,brazil and cambodia.11 
Causative organism: 
Scientific work suggests that Mycobacterium tuberculosis evolved from a 
common human specific pathogen about 40000 years ago. .the evolution of the TB 
bacilli is closed linked with migration of human beings out of africa .the bovis 
species evolution has been linked with the domestication of animals.12 
The tubercle bacilli is an aerobic, acid fast bacilli.the acid fastness is due to 
the peptidogylcan layer linked with the mycolic acid in the cell wall. This 
arrangement is one of the virulent characters of the organism as its difficult for the 
antibiotics to penetrate the cell wall and to the action of the antibodies..cell wall 
has another component , lipoarabinomannan which eases the intracellular survival 
of the organism. 
Regarding the evolution of TB bacilli, In a study by cristina gutierrraz ,the 
author says that “scientists show that the TB bacilli is able to exchange parts of 




TB is a disease thats spread by aerosols.factors which influence the 
transmission are 
1) Ventilation in the room 
2) Number of bacilli in the droplet 
3)Exposure to UV rays 
Primarily its a disease affecting the lungs. 
Greek physician and the father of medicine Hippocrates said phthisis, the 
other name for tuberculosis as “ulceration of lungs, thorax accompanies by cough, 
fever, and consumption of the body by pus”.13 
No wonder the disease was also called a consumption disease. 
In a study by Sheela V.Shenoi et al in the journal of current HIV reports in 
2013 says that “prevention of tuberculosis requires airborne infection control 
methods and such methods have been ignored and with grave consequences”.14 
In yet another study by Riley et al published in the American journal of 
epidemiology confirmed the airborne transmission and its association with 








In a study by parsons et al on the laboratory diagnostic aspects of drug 
resistant TB states “the main reasons for the requirement of multiple drugs to 
effectively cure Tb is because of the hydrophobic cell envelope surrounding 
members of the Mycobacterium tuberculosis complex that serves as a permeability 
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barrier to many compounds; the sequestered, non replicating sub population of TB 
that is affected by drugs only when the cells reemerge from dormancy; and the 
drug target or drug activating enzymes in TB that are altered by mutation and result 
in a population of drug resistant cells”.16 
The primary defense system is the airway itself. The infectious droplets 
when inhaled are caught in the mucus secreted by the goblet cells of the respiratory 
tract. The cilia present in columnar epithelium push the trapped bacilli upwards by 
their movement. 
 Those bacilli which escape this primary defense mechanism are engulfed 
by the alveolar macrophages which are present in the lungs. This is the second life 
of defense. Macrophages are cells which need no previous exposure to get 
sensitized. The action of macrophages starts a chain of events which result in either 
containing the infection or the bacilli able to withstand this defense too. At last to 
be an active disease all depends on this delicate balance, the immunity of the body 
and the invading bacteria. 
Inside the macrophages the bacteria continue to multiply, the macrophages 
began to release a few immune markers like cytokines and proteolytic enzymes. 
This attracts the T lymphocytes and marks the cell mediated immunity. This forms 
the third step of defense. 
The end result of this cell mediated immunity is destruction of the lesion 
(granuloma) into a necrosis, in some cases, the lesion is replaced with fibrosis, 
while in some cases where the immune system is weak the lesion progresses 
further to primary progressive tuberculosis. 
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The TB bacilli is contained within the lesion, which may be activated later 
when the host immune defenses are weak..this dormant lesion is called latent 
tuberculosis. 
In some cases when the lesion erodes into a blood vessel, the bacteria is 
carried to distance sites producing extra pulmonary tuberculosis. If it enters the 
lymphatic system, it reaches the adjacent lymph nodes producing soft cheese like 
necrosis called caseating necrosis. 
Clinical features: 
Depends on the stage of tuberculosis 
1) Latent Tuberculosis:  
MTB can be confined, but difficult to eradicate. Patients with latent TB will 
not have any clinical signs and symptoms. Neither they are infectious. But the 
bacilli is present in them for long time.in case of immunodeficiency as in case of 
AIDS,diabetes, steroid therapy etc the disease may get reactivated. Its more 
common in elderly patients. In a study by kiwanuka et al and lama et al says 
“coinfection with TB has been associated with an increased replication of HIV-1 
and the development of TB disease during HIV infection involves both a 
reactivation of latent TB and increasingly progressive primary TB”17,18 
2) Primary pulmonary tuberculosis: 
This is usually non symptomatic. Only diagnostic tests can detect the 
disease. However the following findings may be detected in case a patient comes 




3) Primary Progressive Tuberculosis: 
Active disease develops in 5-10% of exposed cases. The clinical features 
are nonspecific during early stages.The C/F include: malaise, fatigue, loss of 
weight, evening rise in temperature associated with night sweating. Wasting is due 
to altered metabolism, loss of appetite. Clubbing due to insufficient oxygenation. 
The cough is first dry later becomes productive. If any blood vessel becomes 
ruptured, hemoptysis may occur. Blood tests show anemia and increased leukocyte 
count. 
4) Extra Pulmonary Tuberculosis: 
It occurs in around 20%  of immunodeficient cases. The commonest forms 
include, TB meningitis, TB spine, miliary TB and lymphatic TB. 
In a study by S.K .Sharma and Mohan et al “diagnosing extra pulmonary 
tuberculosis is very difficult. The recent advances in imaging studies can locate 
the site of infection .with the help of biopsy its possible to isolate the bacilli from 
the lesion”.19 
In a study by Sayantan Rat et al 
“The main event in causing miliary TB is the massive lympho-
hematogenous spread of the bacilli from a focus to multiple organs. The main 
organs involve liver, spleen and bone marrow. The predilection to these organs is 
because of many phagocytes in their sinusoidal wall. Miliary TB can be due to 






The pathogenecity is because of the insufficient T cell response. in this 
disease, the recruitment of Teff cells fails to provide an adequate level of immunity 
because of homing of regulatory Treg cells which inhibit teff cells”20 
In a study by bourdin trunz et al in the lancet edition of April 2006 studied the 
effect of BCG vaccination in the prevention of TB meningitis and miliary 
tuberculosis and find that “BCG vaccination is a good cost effective intervention 
against severe forms of TB such as TB meningitis and miliary TB and it should be 
retained in high incidence countries as a strategy to supplement the chemotherapy 
of active tuberculosis”.21 
Multi Drug Resistant Tuberculosis: 
Standard anti tuberculosis has been used for many years since the advent of 
those medicines, however the resistance to them have emerged and is now 
global..there has been resistance at least one drug in all the countries with 
tuberculosis. 
In a study by dorman et al and gandhi NR et al published in lancet states 
“recently multi drug resistant TB and extensive drug resistant TB have had 
devastating effects on populations of HIV infected individuals in developing 
countries, who ironically had good access to HIV care but dies from some 
untreatable form of TB”.22 
MDR TB, there is resistance to isoniazid and rifampicin, the first line drugs. 
The most common cause of MDR TB is faulty treatment. This type of TB can be 
cured by second line drugs. But these drugs are not easily available. Moreover the 
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medicines in the second line had to be taken at least for two years consecutively 
which can reduce patient compliance as well severe side effects. Its to be noted 
that when starting the primary therapy of first line of drugs patient education is 
important creating awareness regarding faulting treatment which the can 
complicate this disease further. 
More worse than MDR TB is the XDR TB or extreme drug resistant TB 
which has high mortality rates. 
In the study about half a million people worldwide developed MDR TB in 
2013. 
HIV and TB: 
Statistics of association between HIV and TB have been described above in 
the statistics. Its noteworthy to mention that the people living with HIV can 
develop active tuberculosis 26 to 31 times more than normal population. Also 
Africa “the dark continent” which has has been subject to numerous disease since 
the origins of mankind is no exception to this association. In 2013 there were 1.1 
million cases of TB among HIV patients, 78% of which were from Africa. This 
may be linked with poor healthcare, AIDS denial ism among many politicians, 
poverty and malnutrition. The origins of AIDS, HIV have been subject to 
numerous conspiracy theories and well disputed by reputed scientists all over the 
world and the disappearance of over a 100 microbiologists in the last decade alone, 
the treatment for AIDS has been disputed among many main stream scientists. 
In studies by klautau GB et al and Murray JF et al in 2005 “HIV mediated 
immunosuppression impairs granuloma formation, resulting in both ineffective 
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containment of Mycobacterium tuberculosis bacilli and diminished formation of 
pulmonary cavities” in a study by poprawski D in 2000 “the above mentioned 
effects cause extra pulmonary disease in HIV-TB subjects”. 
In further studies by pitchenik AE et al, lee MP et al and colebunders R et 
al “the HIV-TB manifests with atypical chest findings, greater involvement of 
lower lobes of the lung and lower concentration of bacteria in sputum”. 
“The world health organization recommends a 12 component approach of 
collaborative TB-HIV activities”. 
In a study by NR Gandhi et al in Lancet says that “MDR tuberculosis is 
more prevalent than previously realized in this setting. XDR tuberculosis has been 
transmitted to HIV co-infected patients and is associated with high mortality. 
These observations warrant urgent intervention and threaten the success of 
treatment programmes for tuberculosis and HIV”.22 
In another study by Diperri giovani et al in lancet says that “In an 
investigation of a nosocomial outbreak of tuberculosis, 18 HIV-infected inpatients 
were found to have been exposed to Mycobacterium tuberculosis; active 
tuberculosis developed in 8, 7 within 60 days of diagnosis of the index case. The 
patients with lower total lymphocyte and CD4 lymphocyte counts were more 
likely to get the disease than were those with higher counts. A low score on 
multiple antigen skin testing was also associated with the development of active 
tuberculosis. 4 of the 18 patients had a positive tuberculin skin test before exposure 
to M tuberculosis; none of them subsequently got the disease”23 
In a study by karp et al on co infection with HIV and tropical infectious 
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diseases states “much of the deadliness of tuberculosis epidemics, especially in 
sub-Saharan Africa has to do with the virulent synergy between HIV and 
tuberculosis”.24 
According to AIDS epidemic update 2009 and WHO global TB control 
update 2009 “out of the 9.27 million incident cases of TB in 2007,an estimated 
1.37 million were HIV positive ;79% of these HIV positive cases were in the 
African region and 11% were in south east Asia region”.25 
In a study by Parsons et al in clinical microbiology reviews “an estimated 
1.3 million deaths occurred among incident TB cases who were HIV positive. 
Infection with HIV 1 increases the risk of reactivating latent TB infection by 80 to 
100 fold and HIV patients acquire new TB infections have higher rates of TB 
progression. Tuberculosis can occur at all points in the immunosuppressive 
spectrum of HIV disease with variable presentations and particularly in high 
burden countries TB may be the first presentation of HIV disease”.26 
According to a study by mukadi et al on tuberculosis fatality rates in high 
hiv prevalence populations in sub Saharan Africa “fatality rates are higher for HIV-
TB co infected patients who are on anti-TB treatment but not on ART than for 
treated TB patients who are HIV negative”.2\7 
In a study by ackah et al on response to treatment, mortality and cd4 
lymphocyte counts in HIV infected patients with tb in abidjan states that “highest 
death rates occur in co infected patients with lowest CD4 counts”.28 
According to world health organization 
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“Latent tuberculosis infection (LTBI) is a state of persistent immune response to 
stimulation by Mycobacterium tuberculosis antigens without evidence of 
clinically manifested active TB. A direct measurement tool for M. tuberculosis 
infection in humans is currently unavailable. One-third of the world’s population 
is estimated to have LTBI: they do not have active TB disease but may develop it 
in the near or remote future, a process called TB reactivation. The lifetime risk of 
reactivation for a person with documented LTBI is estimated to be 5–10%, with 
the majority developing TB disease within the first five years after initial infection. 
However, the risk is considerably higher in the presence of predisposing factors” 
In a study by farba karam et al, 
“The identification and treatment of latent TB infection in HIV positive 
individuals is one of the main recommendations developed by the World Health 
Organization in order to reduce morbidity and mortality in HIV patients living in 
high TB prevalence areas. Tuberculin skin testing has been shown to be highly 
inadequate for identifying LTBI in HIV infected individuals, as the anergy to skin 
testing may lead to false negative results. More sensitive and specific diagnostic 
tools are therefore urgently required. The study showed that, EC-ELISPOT 
(enzyme linked immuno spot) assay appears more sensitive than the TST in HIV 
infected individuals, but this sensitivity appears impaired in those with severe 
immuno-suppression.”29 
Lab Diagnosis : 
Research in new diagnostics, treatment and prophylaxis for tuberculosis is 
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happening in a fast pace. The global plan to stop TB formulated a plan to make 
these new modalities available to resource less countries and high TB prevalent 
areas. This organization involved in the adoption, introduction and implemention 
of these new techniques. 
In study by harries AD in 2001 “Up to 20% of all the TB patients in sub 
Saharan Africa, whom the treatment is initiated die within a year and 2/3 rd of 
these deaths occur in first 2 months”.30 
Isn’t this pathetic? This study reveals that the delay in detection of TB due 
to inadequate diagnostic techniques resulting in patients presenting in advanced 
stage of the disease. 
In a study by Pai M on novel and improved technologies for tuberculosis 
diagnosis in the journal of clinical chest medicine states that “the WHO stop TB 
partnership's new diagnostics working group and foundation for innovative new 
diagnostics (FIND) have classified tools for the diagnosis of TB as the following: 
1) WHO endorsed Tools 
2) Tools in late stage development or evaluation 
3) Tools in early stage development.”31 
In a study by lange C et al and pai M et al states that “considerable effort 
and resources have been invested in developing novel diagnostics and improving 
existing ones”.32,31 
In studies by madebo T et al &liam CK et al “patients in many countries 
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with high TB burden do not receive diagnosis for 3-6 months”.33,34 
The world health organization said “although the treatment success rates 
are improving every year, case detection rates are increasing more slowly”. 
In the journal of clinical microbiology review linda M parsons et al states 
“the global awakening to TB's devastating impact on vulnerable populations has 
been brought about in many countries by its deadly synergy with HIV. In response 
WHO has provided several key guidance documents for national TB control and 
laboratory programs for the use of LED microscopes to improve the sensitivity of 
a turnaround time of front line assay, sputum smear microscopy, and for improving 
the accuracy of TB detection and drug susceptibility testing through the use of 
liquid culture and molecular line probe assays”26 
In a study by madhukar pai in the new tools and emerging technologies for 
diagnosis of tuberculosis states that “despite this enormous burden (high 
prevalence of TB) case detection rates are low posing major hurdles for TB 
control”.31 
In the African continent alone, less than 50% of cases are being detected by 
the currently adopted DOTS programmes. There are new challenges to this like 
drug resistance and HIV co infection. 
In studies by perkins MD et al & WHO global tuberculosis control report 
2010 states that “the dual specters of TB and AIDS have drawn recent attention to 
the lack of suitable diagnosis for TB”35 
In study by study by Keeler E et al on reducing the global burden of 
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tuberculosis states that “TB case detection is the first hurdle towards tackling the 
TB epidemic”.36 
In studies by abe C et al, beavis et al, down et al states that “to address the 
need for rapid and sensitive identification of Mycobacterium tuberculosis and 
other mycobacteria, various genotyping methods for routine diagnosis have been 
introduced during the past decade”.37,38,39 
In a study by fisher M on diagnosis of MDR TB states that “Theres a long 
standing need for new, rapid, accurate and convenient tests for TB diagnosis and 
drug resistance is currently being addressed by several agencies and group”40 
In a study by perkins et al in the topic admitting defeat in a journal states that 
“conventional tests for detecting drug resistance are slow, complicated, expensive 
and difficult to perform in field conditions”35 
In a study by Moore DF et al & campos M et al states that “a highly sensitive 
rule in test can significantly improve the case detection whereas a highly specific 
rule out test can reduce the turnaround time and the duration of respiratory 
isolation as well as unnecessary administration of potentially toxic drugs”.41,42 
In a study by lemaire J et al on advances in the diagnosis of tuberculosis 
states “despite the recent advances in TB diagnosis, cost and accessibility continue 
to be the major limiting factors in the effort to eradicated tuberculosis”.43 
In a study by catharina C.Boehme et al states that “improved technologies that can 
abbreviate the diagnostic process and facilitate early diagnosis can save patients 
time and money, decrease morbidity, improve treatment outcomes, and interrupt 
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the transmission of the disease”.44 
In a study by perkins in the international journal of tuberculosis and lung 
diseases states that “such technologies need to be more sensitive, faster in yielding 
results and simpler to use than microscopy”35 in a study by Pai M et al in the 
national medical journal of india states “better efforts to control TB require faster 
and more accurate diagnostic tests”.31 
According to WHO any new technique for diagnosing TB should have the 
following things to be considered: 
 Should be evidence based. Not only should the test be effective in 
controlled trials but also should perform well in actual field conditions 
 The program readiness: the implementation of any technique requires 
change in national policy and treatment guidelines. 
 Turnaround time: results should be faster than existing ones 
 cost effective 
 quality control measures strictly adhered 
 biosafety precautions adopted 
 adequate staff training 
The currently available diagnostic techniques at a glance 
1) Sputum microscopy: its 125 years old technique and remains the most common 
method used in the diagnosis of TB. 
In a study by geojith george et al states that “notwithstanding the advent of 
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novel diagnostic techniques, smear microscopy remains the most practical test 
available in resource limited settings, where majority of the TB is present”.45 
Its rapid and requires little training to the technicians and no bio safety 
levels are required. 
In a study by steingart KR on fluorescence vs conventional sputum smear 
microscopy for TB states that “microscopy is rapid, specific and inexpensive but 
has low sensitivity”46 it depends on the bacterial load in the specimens and detects 
around 50% of all active cases. Sensitivity is very low (20%) in children and HIV 
patients. The cons include inability to detect resistance to drugs. 
In a study by mathew P et al in journal of clinical microbiology and expert review 
of molecular diagnostics 2010 states that “while cheap and relatively easy to 
perform, the more than 125 year old smear microscopy method has only modest 
sensitivity (35-80%) and cannot differentiate between drug sensitive and drug 
resistant Mycobacterium tuberculosis”47 
 In a study by dye et al on evolution of TB control and prospects of reducing 
TB incidence report “the human immunodeficiency virus epidemic has further 
diminished the utility of routine microscopy and smear negative TB has arisen as 
a particular problem in sub Saharan Africa”.48 
The patient has to come twice to the clinic. Once to give the specimen and 
second to collect the results. This means the transportation costs and the loss of 
pay. 
In studies by foulds J et al in the new tools for diagnosis of tuberculosis and 
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perkins MD et al in international journal of tuberculosis and lung diseases the 
limitations of conventional methods of diagnosis including smear microscopy 
have been explained.49&35 
In parsons et al on clinical microbiology reviews states “in high incidence 
countries, TB control relies on passive case finding among individuals self-
presenting to healthcare facilities, followed by either diagnosis based on clinical 
symptoms or lab diagnosis using sputum smear microscopy. Serial sputum 
specimens are required which means that the people are asked to make repeated 
visits to the health care center for specimen delivery and collection results. For 
many patients, the costs of repeated visits to health care facilities are prohibitive 
and patient dropout is a significant problem”26 
In a study by squire sb et al in 2005 “in places where HIV is prevalent, the 
proportion of cases detected by smear microscopy is 20-30%.to address this issue 
multiple sputum examinations was done due to which a relatively large number of 
patients do not complete the testing”.50 
In a study by steingart et al published in lancet “sensitivity of sputum smear 
microscopy has been reported to vary from 20-80% often depending on the 
diligence with which specimens are collected ,smears are made and stained smears 
are examined”.46 
In a study by getahun et al published in lancet states “Tb smear microscopy 
is highly insensitive for HIV co infected individuals and for children due to the 
reduced pulmonary bacillary loads in these patients”.51 
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In study by harries ad et al in 2003 “more than a third of patients with smear 
negative TB in Malawi needed more than 6 visits to a health care center for 
treatment to be initiated”52 
This is due to the difficulties in confirming smear negative TB, underlines 
the need the new and simple, yet rapid and effective diagnostic methods to address 
such cases. 
In parsons et al clinical microbiology reviews states “in resource poor 
countries many smear microscopy labs are single room and insufficiently staffed 
with poor maintenance of microscopes. These labs don’t have consistent clean 
water supply and electricity. There are few opportunities for the training of staff 
and little staff capacity to handle high volume workloads. Quality assurance 
programs including quality control and external quality assessments are often 
lacking. This a critical need for new, sensitive, easy and paid point to care 
diagnostics and also for investments in laboratory infrastructure, quality assurance 










In a study by monkongdee et al states “the who recommendation is two 
rather than three sputum examinations be used was generated largely for non -HIV 
patients. However this approach was evaluated in HIV infected patients in 
Southeast Asia and the incremental yield of microscopy was found to rapidly 
diminish to 2% after the second smear.53 
According to who laboratory policy in 2007 “for TB detection two sputum 
smear are to be collected and examined”. 
The above policy was drafted based on a meta-analysis of 37 studies which 
quanitified the incremental yields of serial sputum specimens. 
In a study by mase at al in 2007 states “85.8% of Tb cases were detected 
with the first sputum specimen. With second sputum specimen, the average 
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incremental yield was 11.9%, while the incremental yield of third specimen, when 
the first two were negative was 3.1%”54 
In a study by bonnet et al in 2007 conducted in Kenya shows “decreasing 
the number of smears examined for detection of TB leads to reduction of patient 
visits to clinic and lab workload”.55 
It is to be mentioned that the above reasons are major drawbacks of multiple 
smear examinations and prevent patient from taking from collecting the results 
thereby diagnosing TB. 
In a study by aziz et al tells “screening of TB patients from three to two 
specimens should be recommended only in settings with a well-established lab 
network and a fully functional EQA program for smear microscopy including on 
site evaluation and follow up training for problem laboratories”.56 
It’s a well-known phenomenon that most of the labs in our country don’t 
have quality control assessments. 
In a report by world health organization-strategic and technical advisory 
group for Tuberculosis (STAG-TB) dated 2009 recommends “conventional 




In a study by steingarta kr et al “a meta analytical study of 45 studies show 
that the sensitivity advantage of fluorescence microscopy over conventional 
microscopy is greater by 10%”.46 Also sputum processing increases the chance of 
finding TB bacilli my microscopy by 13-33%. 
Tb Culture: 
It is the gold standard test. Most sensitive method and accommodates DST 
and speciation. Takes about 2-8 weeks since the TB bacilli is a slow growing 
organism having a slow generation time of 14-15 hours. Standard method is using 
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WHO STOP TB report 2008 “some national TB programmes in developing 
countries have no functioning TB culture facility at all. In others its done only in 
national reference labs and high grade hospitals. Few countries have the capacity 
for DST”. 
Because of the shortcomings, automated liquid systems have been 
developed. 
In a study by william -bouyer n et al “these systems detect the O2 
production, CO2 consumption by radiometry, calorimtery, pressure sensors and 
decrease the time to detection by half”.57 
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Disadvantage if this system includes contamination especially when 
inexperienced and difficult to examine the colony morphology. 
In a study by van kampen sc “the liquid culture systems suffer from 
important shortcomings as they are prone to contamination, human resource 
intensive, costly”.58 
 
In studies by kocagoz t etal &baylan o et al “solid media called TK uses a 
colorimetric method to find the bacterial growth. Its possible to discriminate and 
differentiate non tuberculous bacteria in this method. IT’S cheap and rapid. 
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Detection time is 10 days less than conventional LJ media”.59&60 
In study by farnia p et al “a number of redox reagents have been developed 
to find the bacterial growth in early cultures”. This needs further evaluation.61 
MODS-microscopic observation drug susceptibility: 
Manual technique in which the colonies of the culture are examined under 
a microscope, in this case an inverted microscope is used. 











Cons: the technique need training to technicians, bio safety level 2 precautions 
and difficulty in differentiating between NTM and MTB. 
In a study by Moore DA et al “by adding Anti TB antibiotics to adjacent 
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wells and examining for comparative growth, MODS can be applied for early 
detection of DST as well”.62 
In a recent study on a large scale carried out in Peru by Moore DA et al 
“MODS detected 94% of 1908 culture positive cases whereas LJ medium detected 
only 87%”.62 The average detection time in this method was only 8 days. 
This seems to be a promising too. 
 
Septi check AFB method: 
In the ICMR bulletin dated 2002 “it is non radiometric method has the 
unique advantage of simultaneous detection of MTB, NTM and contaminants”.63 
In a study done in USA by isenberg HD et al shows “the system gives a better 














Radiometric BACTEC 460 TB method: 
14C labeled palmitic acid in 7H12 medium is used. When MTB grows 14C 
is generated which is measure by the system. The system also identifies MTB as 
well as can be used for DST. 
In a study done in TRC, chennai by Venkatraman Et al shows “rate of 
isolation of positive cultures was significantly faster with the BACTEC method 
with 87% of the positives obtained by 7days and 96% by 14 days.DST could be 









MGIT 960 mycobacteria detection method: 
In this method, O2 utilization by MTB is determined by a fluorescent dye 
in the medium. Its an automated system. 
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In a study carried out in usa by tortoli et al “this system exhibits a potential 
for rapid, accurate and cost effective detection of MTB especially in high volume 
settings”66 
MB/Bact system: 
It’s a non-radiometric methods based on the colorimetric detection of Co2. 
In a study by rohner et al concludes “this systems is a good alternative to 











ESP culture system 2: 
Automated system based on the detection of pressure changes in the media 
in a study by woods et al “it’s a reliable, less labour alternative to BACTEC, 







Phage based test: 
Underlying principle: the ability of phages to infect bacteria has been used. 
A lytic mycobacteriophage D29 infects the TB bacilli and killed with a 
virucide.this procedure only kills the virus and not the bacteria inside, later the 
cells are plated on a lawn of Mycobacterium smegmatis producing plaques 
indicating the disease (TB). The test could be done in days. 
In studies by albay a et al, butt t et al “this test detects 29%-87% of smear 
positive cases and 13-78% of smear negative cases in 2 days”.69,70 
In a study by alcaide F et al “the capacity of D29 phage to replicate in 
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nontuberculous mycobacteria has not impaired clinical specificity which remained 
high (99.1%) even in a study in which 30% of all culture isolates were non 
tuberculous mycobacteria.71 
This technique requires necessary infrastructure. 
Immunodiagnosis 
In studies by gennaro ML et al, daniel TM et al ,bothamley GH et al, 
“immune based tests for detection of antigen, antibody and immune complexed 
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have been reviewed”.70,71,72 
There's no such test available yet to replace smear microscopy and culture. 
The problem is these test aim at detecting the humoral response rather than the cell 
mediated immunity which plays a prominent role in TB. 
The above mentioned studies have analyzed the reason for failure of such 
tests. 
In studies by Laal S et al “the Tb is characterized by a wide spectrum from 
latent to active and in each stage different set of antigens are expressed, and even 
in a single stage the antigens are not the same, for eg: its different from cavitary 
lesions and the disease with non cavitary lesion”73 
Hence any serological test should encompass to detect all these antigenic 
responses. Previously crude antigens were used, which led to poor specificity. 
In review by Madhukar Pai et al “the development of recombinant proteins 
specific to MTB has partially overcome this problem”.74 
Many serological tests employ a single antigen and hence the detection of 
disease during all stages is less. In the above mentioned studies “the development 
of a cocktail of antigens specific to each stage of the disease has partially addressed 
this problem”. 
Lipoarabinomannan assay: 
It’s a heat stable glycolipid present in the cell wall of mycobacteria. 
Instead of searching for an antibody response specific to an antigen, this 
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test aims at finding the specific antigen using a capture ELISA method 
This method has demonstrated some success. Further evaluation needed. 
Interferon gamma release assays (IGRAs): 
It’s a diagnostic immune response Tb test. The standard Mantoux or 
tuberculin sensitivity test has many limitations. This new tests measures the cell 
mediated immunity in response to MTB specific antigens which are not present in 
BCG and NTM there by specific to MTB. Two tests are currently available. The 
quantiferon TB gold test and the T spot TB test. The best thing is prior BCG 
vaccination does not give a positive test, thereby useful in screening. 
This test is not without limitations. There's no evidence to find which case 
with progress to active disease based on this test. 
MPB64 skin patch test: 
MPB 64 is a Mtb specific protein. In research by Nakamura et al in japan 
in 1998 “the test was capable of eliciting a distinct response from individuals with 
active but not latent TB, the sensitivity was 98% and specificity was 100%”.75 
An aqueous solution containing MPB64 is applied to the gauze and over 









Also it could be used in lateral flow assays in differentiating Mtb from 








Nucleic acid amplification tests (NAT) are designed to amplify regions 
specific to MTB complex. They are available as commercial kits. In USA amplicor 
and MTD are FDA approved. In studies by Piersimoni C et al & Hugget Jf et al 
“the 3 widely used methods are PCR, transcription mediated amplification (TMA) 
and strand displacement amplification. These methods show excellent speed and 
specificity, sensitivity approaching but not equaling culture”.76,77 
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In house NAT are predominantly used in research settings. In studies by 
Brodie et al, Pai M et al “the literature of NAT has been extensively reviewed” 
In meta analytical studies by Flores L et al, Pai M et al “the results 
demonstrate that AT have high specificity for both pulmonary and extra pulmonary 
TB”.78&31 
In review by Madhukar Pai et al in the journal of expert review on 
molecular diagnosis “high specificity and positive predictive value confer clear 
advantages in terms of the tests ability to rule in TB. A positive NAT in a patient 
with a high pretest probability is fairly confirmatory of TB, particularly in smear 
positive cases”.79 
It also says “the sensitivity of NAT is lower and highly variable across 
studies. In many studies, sensitivity estimates have been lower in paucibacillary 
forms of TB. Therefore a negative test does not rule out TB”. 
A negative NAAT with a positive smear can be non-tuberculous 
mycobacteria. 
Disadvantages: Cannot differentiate between live and dead bacilli as the DNA 
can be amplified in both cases. 
In a meta analytical study by Flores et al on the accuracy of in house PCR 
tests “the use of IS6110 as an amplification target and the use of nested PCR were 
associated with higher accuracy”79 In the ICMR bulletin dated august 2002 
“IS6110 is specific for MTB and is present upto 20 times in its genome, thus 
offering multiple targets for amplification”.63 The author Madhukar Pai et al in this 
review concludes that “in general, the concerns about accuracy, reliability and 
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requirement for necessary infrastructure reduce their applicability in resource 
limited settings”.74 
In a study by Suffys P “even in established molecular labs, the performance 
of NAT is highly variable, implying the need for more robustness”.80 
One such promising technology is the LAMP, loop mediated isothermal 
amplification. It was invented by Eiken chemicals, japan. 
In study by Iwamoto T et al “the advantages of this technology is that it 
uses 6 specifically designed primers and a single polymerase with strand 
displacement activity, requires no thermocycler, it’s a closed system needing no 
bio safety levels and gives a visual readout by naked eye”.81 
In study by Boehme C et al “preliminary data suggests that this test can be 
done in a benchtop by technicians with no molecular training detecting all smear 
positive specimens and half of the smear negative specimens”.82 
The inventor Eiken in its website claims that “the amplification efficiency 





Gene x pert: 
This test detects both MTB and rifampicin resistance. This is a hemi nested PCR 
In a study by Helb D, Blakemore R “in this test PCR amplification of five 
overlapping probes that are complementary to the entire 81 base pair RIF 
resistance determining region of the MTB rpo B gene and subsequently probes this 
region for mutations that are associated with Rifampicin resistance”. 
Disadvantages include high cost. In a review by Mark D Perkins et al 
“FIND(foundation for innovative and new technologies) is working with cepheid 
to develop a real time PCR assay for TB on its gene xpert platform that automates 
sputum processing, DNA extraction, gene amplification and target detection into 
a single, hands free test”.35 
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Line probe assays: 
In review by Madhukar Pai et al says “line probe assays are are strip based 
tests that use PCR and reverse hybridization methods for the rapid detection of 
mutations associated with drug resistance and detection of MTB complex”.74 
 
In a meta analytical study Morgan et al “the line probe assay has high 
sensitivity and specificity when culture isolates are used, less when directly 
applied on clinical specimens”84 




Materials and methodology: 
This is a comparative evaluation of three techniques, fluorescence 
microscopy, culture using solid media and LAMP PCR. 
This study is done in Tirunelveli medical college hospital over a period of 
four months from June 2015 to September 2015 
Sample selection: 50 samples randomly collected from the district tuberculosis 
center, from patients suspected of tuberculosis as referred by expert thoracic 
physicians in the department of thoracic medicine. 
1) Fluorescence microscopy: 
Principle: 
Mycobacteria are acid fast.ie. They resist decolorizing even after exposure 
to acid. In this technique carbol fuschin is replaced with auromine -O. The mycolic 
acid in the cell wall has an affinity for fluorochromes. The counter stain to 
differentiate the background is potassium permanganate. The advantage is greater 
area can be examined under low power microscope thereby enabling a larger area 
to be examined in a less time. 
The mycobacteria appear as yellow luminous rods. 
Sputum smear preparation: 
Label a new clean slide using a 5mm nichrome sterile loop transfer sputum 
to the slide smear the slide for an area of 2-3 cm air dry for 15 minutes heat fix by 





















































The procedure was followed as per TBC India guidelines. 
The following reagents were required 
1) 3% phenol: 
2) Auramine-phenol solution 
3) Acid alcohol 
Auramine-phenol preparation: 
3% phenol 100 ml was warmed to 40ºC 
0.3 gm of auramine was added and shaked for 10 minutes 
The solution was filtered using whatman No.1 filter paper and stored in a 
dark glass bottle. 
Acid Alcohol preparation 
0.5 ml HCL 
0.5 gm NaCl 
75 ml absolute alcohol 
25 ml distilled H20 
4)0.1% KMnO4 
2) Culture In Lowen Stein Jenson Media: 
Mucoid or mucopurulent sputum for cases suspected of pulmonary 
tuberculosis was collected from the district TB center, department of thoracic 
medicine, tirunelveli. 
The specimen was labeled and the laboratory number of each specimen 
noted. 




The specimens were decontaminated by modified petroff's method as per 
TBC guidelines. 
Specimen should be processed as described below: 
1.5 ml of sputum in universal container is transferred to centrifuge tube 
and double the volume of NaOH 4% is added 
↓ 
2. the tubes are inverted and the sputum is mixed well. 
↓ 
3. the tubes are kept in votex shaker for a minute and then in incubator at 37ºC 
for 15 minutes 
↓ 
4.after 20 minutes, 15 ml of distilled water is added to the tubes 
↓ 
5.  centrifuged at 3000 x g for 15 minutes. 
↓ 
6.supernatant fluid discorded in a disinfectant solution( bleach solution) 
↓ 
7. another 15 ml distiller water added and centrifuged at 3000 x g for 15 minutes 
and the supernatant discarded. 
↓ 













Reading Of Cultures: 
The colonies of Mycobacterium tuberculosis appear as rough, buff, like 
bread crumbs and appear 2- weeks after incubation 
If the colony has doubtful morphology then Ziehl Neelson staining is 
done.if no afb is seen then the culture is discarded as contamination. 
If smear positive then the following biochemical tests were done 
1) Niacin 
2) Nitrate 
If both were positive, then Mycobacterium tuberculosis was confirmed. If 
niacin is negative then depending on the pigmentation and morphology they were 
grouped under BCG or M.bovis and non-tuberculous mycobacteria. 
Flow chart depicting the identification of tubercle bacilli based on growth 































the findings were reported as per below 
Reading of culture report 
No growth Negative 
1-100 colonies positive(number of colonies) 
>100 discrete colonies Positive 2+ 
Confluent growth Positive 3+ 
contaminated contaminated 
<20 colonies of only NTM is one or 
both slopes 
No growth 
>20 colonies of only NTM in both 
slopes 
Negative for M.Tb 
 
media was prepared as per annexure 1 attached 
freshly prepared lowenstein jenson medium to be inoculated before keeping in 
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3) LAMP PCR: 
DNA purification procedure: 
1) From the pellet prepared by homogenisation and decontamination after 
inoculation into the LJ slopes the remainingis used. 
2) Add 180μl of digestion buffer and 20μl of lysozyme .votex for 10 seconds 
3) Incubated at 37ºC for 15 minutes 
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4) 200μl of binding buffer and 20μl of proteinase K added.mixed well using votex 
5) Incubated at 56º C for 15 minutes 
6) 300μl of ethanol added and mixed well by inverting several times. 
7) Pipette entire sample into the spincolumn. Centrifuged at 10000 rpm for 1 
minutes. Discard the flow through and place the column back into the same 
collection tube. 
8) 500μl of wash buffer-1 added to the spin column. Centrifuged at 12000 rpm for 
I minute and the flow through discarded. Place the column back into the same 
collection tube. 
9) Add 500μl of wash buffer-2 to the spin column .centrifuged at 12000 rpm for 1 
minutes and the supernatant discarded. The column is placed back into the same 
collection tube. 
10) Repeat wash buffer-2 wash once 
11)  Centrifuge the spin column with collection tube at 13000 rpm for 1 minute 
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12) Discard collection tube and transfer the spin column into a fresh 1.5 ml fresh 
micro centrifuge tube. 
13) Add 100μl of prewarmed elution buffer to the centre of the spin column 
membrane 
14) Incubate for 2 min at room temperature and centrifuge at 13000 rpm for 1 
minute.discard the spin column and store the purified DNA at -20ºC. 
Materials required: 
Pure fast bacteria; DNA mini spin purification, isothermal master mix, 
SYBR green Dye and primers are from helini biomolecules isothermal master mix 
contains: reaction buffer, 1.6mM of dNTP mix, 0.5 M of betaine, 6mM of 
MgSO4,8U of Bst DNA polymerase 































Loop Isothermal Master Mix 10μl 
Primer Mix 5μl 
Purified DNA 5μl 




Negative control and Positive control are included in every run. 
Centrifuged and incubated at 65°C for 1hour. 
Visualization 
1μl of 10X SYBR Green dye added to each PCR tube and gently mixed by 
vortex and placed over UV transilluminator and illumination are compared with 
Negative control and interpreted. 


















Table 1- age wise distribution: 
Age No of Subjects Percentage 
<30 9 18% 
31 to 40 9 18% 
41 to 50 9 18% 
51 to 60 12 24% 











In the present study 18% of the study population was below the age of 30, 
18% between 31-40, another 18% between 41-50, 24% of the cases were between 






































In the present study among 50 samples collected , 39 (78%) were males and 












Table 3-Culture results: 
Culture   
 Positive Negative 
Male 32% 46% 



































Table 4-PCR results: 
Lamp PCR  
 Positive Negative 
Male 40% 38% 






























Table 5-Smear results: 
Smear   
 Positive Negative 
Male 52% 26% 





by fluorescence microscopy was positive in 56% of the subjects were as negative 





























Sample table   
    
  Positive Negative 
 Male 0% 0% 





Table -6comparison of smear 
with culture: 
 
    Culture   
    Positive Negative 
Smear Positive 13 15 























Agreement 9.7Z%  
P value P value 0.474  
0.21    
 
When compared with the gold standard “culture in solid media” the smear 
microscopy using LED fluorescence showed sensitivity of 62% and specificity of 
48% 
Positive predictive value was 46% 
Negative predictive value was 64% 
p value in McNemar test is 0.21 
kappa agreement is 9.72% 
p value for kappa agreement is 0.474 
 
Table-8 comparison between PCR and culture: 
    Culture   
    Positive Negative 
PCR Positive 20 6 






Table 9-sensitivity and specificity of PCR: 
 
 
Statistic Formula Value 95% CI 
Sensitivity 
 
95.24% 76.18% to 99.88% 
Specificity 
 
79.31 % 60.28% to 92.01% 
Positive Likelihood 
Ratio  
4.60 2.24 to 9.45 
Negative Likelihood 
Ratio  
0.06 0.01 to 0.41 
Disease prevalence 
 




76.92% (*) 56.35% to 91.03% 
Negative Predictive 
Value  






P value P value <0.0001 
0.125   
 
The sensitivity of the LAMP PCR was 95.24% , specificity being 79.31% 
with a confidence interval of 95% 
Positive predictive value was 76.92% 
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Negative predictive value being 95.83% 
McNemar test P value :0.125 
Cohen's kappa :72% 
Kappa agreement P value:<0.0001 








As tuberculosis is one of major causes of death and is preventable if taken 
appropriate measures. The foremost is detecting the disease in an early stage and 
initiating treatment thereby preventing its spread. The earlier methods of 
“sanatorium”, isolation have been proved inadequate when compared with 
antibacterial treatment in preventing the spread. 
In this study we compare LAMP PCR & fluoresce microscopy with culture 
using Lowenstein Jenson media in 50 clinical specimens (sputum) collected from 
cases suspected of tuberculosis for the diagnosis of Mycobacterium tuberculosis. 
The laboratory diagnosis of tuberculosis chiefly relies on smear 
microscopy. The Ziehl Neelson method of acid fast staining is routinely carried 
out and the RNTCP has phased the fluorescence microscopy as an alternative 
method whereby the time to examine more fields can be reductionis is because the 
low magnification used to examine the fields, thereby examining more fields in a 
single sitting. The time consumed by fluorescence microscopy to examine 100 
fields is 2 minutes by experienced personnel. 
However the technique has limitations in that its sensitivity and specificity 
are less and identification of species is restricted which makes the need for a better 
technique with same robustness, speed, cost effective with no additional expenses 
for manpower training and bio safety levels which can penetrate the rural and 
inaccessible areas of the TB endemic areas to find the TB bacilli and thereby 
initiating treatment. 
In a study by Mathew P et al in journal of clinical microbiology and expert 
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review of molecular diagnostics 2010 states that “while cheap and relatively easy 
to perform, the more than 125 year old smear microscopy method has only modest 
sensitivity (35-80%) and cannot differentiate between drug sensitive and drug 
resistant Mycobacterium tuberculosis”47 
In a study by Steingarta KR et al “a meta analytical study of 45 studies 
show that the sensitivity advantage of fluorescence microscopy over conventional 
microscopy is greater by 10%”.46 
The culture is a gold standard, useful in identification of species as well as 
high sensitivity and specificity, it has shortcomings in that it needs 8 weeks’ time. 
In this study we compare LAMP PCR & fluoresce microscopy with culture using 
Lowenstein Jenson media in 50 clinical specimens (sputum) collected from cases 
suspected of tuberculosis for the diagnosis of Mycobacterium tuberculosis. 
The sensitivity of the smear microscopy in this study is 62%.this is in 
accordance with earlier study by Mathew P et al in which “the sensitivity of the 
smear microscopy is 30-80%”46 
It should also be noted that fluoresce microscopy improves the detection 
rate by another 10%. 
The 62% sensitivity rate of the smear microscopy in this study indicates 
better lab practices, experienced technicians and the high prevalence of TB in this 
area. 
In the study Geojith et al says “Smear microscopy detects the morphology 




LAMP detects the presence of DNA in the specimen whether live or dead 
the organism may be.these two techniques are complementary to each other in the 
sense LAMP detects the genetic material more when the smear and culture results 
are positive. 
In this study LAMP shows an excellent sensitivity of 95% which is in 
higher than earlier study by geojith et al in which the sensitivity was 79.5%  .earlier 
studies showed better specificity. 
This is in accordance with our study. 
In a study by Pal N sharma et al in the indian journal of pathology “78.65%  
specimens were culture positive when processed within 48 h by the NaOH method. 
The culture positivity in the same specimen that were stored with cetylpyridinium 
chloride and processed after 7-8 days was 70.22%, whereas those stored without 
CPC and processed by the NaOH method was 46.62%”85. 
In a study by catherine Boehme et al “The sensitivity of LAMP in smear- 
and culture-positive sputum specimens was 97.7%  and the sensitivity in smear-
negative, culture-positive specimens was 48.8%”.82 
The sensitivity of the above study is higher than the present study. 
In a meta analytical study by daphne I, madhukar pai et al “commercial NAAT 
techniques are highly variable, the sensitivity is inconsistent with the specificity. 
The study further holds that based on the observation its not recommended for 
NAAT to be replaced for the conventional tests in the present situation”.86 
It is to be mentioned that a study should have a higher sensitivity and 
specificity. It it has lower specificity then more persons who dont have disease are 
73 
 
identified to have disease and further investigations are ordered or treatment 
started which is detrimental to patients health and unnecessary expenditure. 
According to WHO report on the use of nucleic acid amplification tests for the 
diagnosis it states that in one large study the sensitivity was only 53%. 
In a study by olga l et al on the Assessment by Meta-Analysis of PCR for 
Diagnosis of Smear-Negative Pulmonary Tuberculosis 87 Sensitivity ranged from 
9-100% while the specificity ranged from 25 to 100%. 
In a study by lydia kivihya et al on the Comparison of PCR with the Routine 
Procedure for Diagnosis of Tuberculosis in a Population with High Prevalences of 
Tuberculosis and Human Immunodeficiency Virus88 
“The sensitivity and specificity of PCR were 93 and 84%, respectively. HIV 
status did not affect the sensitivity of PCR. A total of 99.7% of the true smear-
positive and 82.1% of the true smear-negative TB patients were correctly 
identified by PCR. PCR detected M. tuberculosis in 11.7% of the culture-negative 
suspects, 60% of which had one or two PCR-positive sputum specimens”. 
This indicates that the PCR technique can be applied to identify smear 
negative pulmonary tuberculosis   
In a study on application of loop mediated isothermal amplification (lamp) 
assay as an alternative diagnostic test for rapid tuberculosis diagnosis in limited 
resource setting 
Sensitivity of LAMP was 97.47% , the specificity being 60.31. the higher 
sensitivity means this test could be used as an alternative for smear microscopy in 
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TB endemic countries like india for rapid and cost effective diagnosis. 
In a study by mitarai ,okumura et al on the evaluation of a simple loop-
mediated isothermal amplification test kit for the diagnosis of tuberculosis 89 
The sensitivity of LAMP using raw sputum in smear- and culture-positive 
specimens was 98.2%  while the sensitivity in smear-negative, culture-positive 
specimens was 55.6% (95%CI 43.4–68.0). 
The test says that the sensitivity of lamp was not lower than the commercial 
amplicor assays for tuberculosis. 
In a study by basu dev pandey et al “Using this system, a total of 200 
sputum samples from Nepalese patients were investigated. The sensitivity of 
MTB-LAMP in culture-positive samples was 100 % (96/96), and the specificity in 
culture-negative samples was 94.2 % (98/104, 95 % confidence interval 90.5–
97.9 %). 90 
In the study by geojith G et al on the efficacy of LAMP in lab detection of 
MTB the sensitivity was 91.7% and specificity was 90.9% in 2 hour format.45 
In the present study the incubation time was 1 hour.increase in incubation 
time increases the sensitivity of the test as per the above mentioned study.The need 
for modification of protocols to give a better effficacy needs to researched in 
further studies. 
In a study by ehsan aryana et al “ the accuracy of the LAMP method was 
tested using restriction endonucleases enzymes to digest the byproducts of LAMP 
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and then visualised using agarose gel electrophoresis”91 
This study confirms the accuracy of the LAMP reaction. 
Recently another study by lee et al 2009, 
One technique called reverse transciption loop mediated isothermal 
amplification combined with enzyme linked immunosorbent hybridisation (RT-
LAMP-ELISA) was used to target the 16S ribosomal RNA.the test detected one 
copy of 16S RNA per reaction .this is comparable with the IS6110 based MTB 
LAMP assay. This technique however is costly compared with LAMP MTB .92 
The cost of single LAMP reaction in our study is Rs.500-/-.whereas the technique 
mentioned above could cost upto 660/reaction. 
If both smear and PCR are positive in clinical specimens then the diagnosis 
of tuberculosis is assumed. 
However in studies by ru-yi zhua et al on the LAMP test correctly identified 
the MTB DNA (M.tuberculosis, M.bovis and BCG strains) & did not detect the 
non tuberculos mycobacteria and other bacteria. This shows the specificity of this 
test.92 
In the study by ehsan aryana et al shows identical sensitivities were 
obtained for LAMP and nested PCR, but the LAMP assay was more rapid and 
cost-effective than the latter. 






The present study aimed at detection of Mycobacterium tuberculosis in 
clinical specimens from patients suspected of tuberculosis with history of fever, 
cough with expectoration for 2 weeks ,loss of weight, apettite and were referred 
for lab diagnosis of Mycobacterium tuberculosis by expert thoracic physicians 
from the department of thoracic medicine, tirunelveli medical college.all the 
sample were collected within a time of 2 months, decontaminated and 
homogenised by modified petroff's method using TBC guidelines.fluorescence 
microscopy was done on unprocessed samples and their results collected, however 
the test is a blinded study and the results were compared at the end of the study. 
The processed specimens were then inoculated in LJ media , freshly prepared 
using a standardized method and the rest of pellet was used to detect MTB by loop 
mediated isothermal amplification.the results were compared at the end of the 
study.the results of the study were analysed and summarised below 
 
The age wise percentage of patients included in the study: 
18% of the study population was below the age of 30, 
18% between 31-40, 
 18% between 41-50, 
24% of the cases were between 51-60 and 
22% of the cases were more than 61 years of age. 




 22% of the study population were females and the rest 78% were males. 
Culture was positive in 42% of the subjects and negative in 58%. 
Graph 4 shows PCR was positive in 52% of the study population and 
negative in 48% cases. 
Graph 5 shows fluorescence microscopy was positive in 56% of the 
subjects were as negative in the rest 44%. 
False negative was seen in one sample. which may be due to contamination. 
False positive was seen in 6 samples 
True positive in 20 samples& 
True negatives in 23 samples. 
Fluoresence microscopy using auromine staining when compared with the 
gold standard “culture in solid media” shows 
Sensitivity of 62% 
Specificity of 48% 
Positive predictive value was 46%, 
Negative predictive value was 64%, 
P value in McNemar test is 0.21, 
Kappa agreement is 9.72%, 
P value for kappa agreement is 0.474. 
Comparison of LAMP PCR with gold standard technique which is culture 
in solid LJ media shows 
Sensitivity of the LAMP PCR was 95.24%, 
78 
 
Specificity being 79.31%, 
Positive predictive value was 77%, 
Negative predictive value being 96% 
P value for Mcnemar test  0.125 
P value for kappa agreement was <0.0001, 
Kappa agreement was 72% 
HIV infected samples were too low and hence were neglected for 
consideration also there was no relevance in the positivity rate for male and female 
patients age wise distribution of the samples did not bear any specific outcome for 
the study. 

















LAMP PCR can be used for detection of mycobacterium tuberculosis 
comples in sputum samples with a high degree of sensitivity and moderate levels 
of specificity. 
In culture and smear analagous samples the sensitivity is higher. The 
important advantage of LAMP is its robustness, speed in detecting the 
organism.the detection time is one hour and needs little training to be done 
However whether its an active or latent infection needs clinical findings and other 
assays like Interferon gamma release assays. 
When used in conjunction with smear microscopy the results are good. A 
large study and subsequent research is required for its implementation as an 
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 Lamp PCR 
results
1 3304 murugeshwari 40 female yes no 1 2 positive 1 not available 29.06.2015 positive 1 positive 1
2 2997 Ganapathy 64 male no yes 1+ 2+ positive 1 neg 08.06.2015 positive 1 positive 1
3 2960 sudalai 41 male yes no 2+ 2+ positive 1 non reactive 05.06.2015 negative 2 negative 2
4 2962 ganeshan 38 male yes no 3 3 positive 1 non reactive 05.06.2015 positive 1 positive 1
5 2948 kannan 48 male no yes 2 positive 1 non reactive 04.06.2015 negative 2 positive 1
6 2929 chelladurai 56 male no yes 1 positive 1 not available 03.06.2015 positive 1 positive 1
7 3009 selvam 45 male yes no 1 1 positive 1 neg 09.06.2015 negative 2 negative 2
8 2954 thomas 40 male yes no 3 positive 1 neg 09.06.2015 positive 1 positive 1
9 2935 kanagaraj 27 male yes 3 3 positive 1 neg 04.06.2015 negative 2 negative 2
10 3031 chelladurai 35 male yes no sc4 sc6 positive 1 positive 10.08.2015 negative 2 negative 2
11 2944 henry 63 male yes no 3 3 positive 1 neg 04.06.2015 negative 2 positive 1
12 2966 baskar 28 male no yes 3 not available positive 1 not available 05.06.2015 positive 1 positive 1
13 3032 kumar 40 male no yes neg sc5 positive 1 neg 10.06.2015 negative 2 negative 2
14 2980 mahalingam 55 male yes no sc12 not available positive 1 not available 06.06.2015 positive 1 positive 1
15 2987 senthilvel 65 male no yes 3 3 positive 1 not available 06.06.2015 positive 1 positive 1
16 3054 subbiah 63 male yes no 1 2 positive 1 neg 11.06.2015 positive 1 positive 1
17 3008 sakthivel 42 male yes no 3 3 positive 1 neg 09.06.2015 positive 1 positive 1
18 2986 manirusamy 55 male yes no sc12 not available positive 1 neg 06.06.2015 negative 2 positive 1
19 2939 chandiran 51 male yes no 1 3 positive 1 neg 04.06.2015 positive 1 positive 1
20 3062 pavithra 35 female yes no neg neg negative 2 neg 02.06.2015 negative 2 negative 2
21 2996 rathinam 50 female yes no neg neg negative 2 neg 08.06.2015 negative 2 positive 1
22 2904 karuppasamy 27 male yes no 3 3 positive 1 neg 02.06.2015 negative 2 positive 1
23 2905 sankaran 58 male no yes neg neg negative 2 neg 02.06.2015 negative 2 positive 1
24 2906 jeyaraj 8 male yes no neg neg negative 2 neg 02.06.2015 positive 1 positive 1
25 2907 muthusamy 70 male yes no neg neg negative 2 neg 02.06.2015 positive 1 positive 1
26 2908 paramisvam 67 male yes no neg neg negative 2 neg 02.06.2015 positive 1 positive 1
27 2909 meeraselvam 26 male yes no 2 2 positive 1 neg 02.06.2015 negative 2 negative 2
28 2910 chellamal 51 female yes no neg neg negative 2 neg 02.06.2015 positive 1 positive 1
29 2994 vadivu 46 female yes no neg neg negative 2 positive 06.06.2015 positive 1 positive 1
30 2911 samudrayan 71 male yes no neg neg negative 2 neg 02.06.2015 positive 1 negative 2
31 2912 rajesh 26 male yes no neg neg negative 2 neg 02.06.2015 negative 2 negative 2
32 2913 kalimuthu 55 male yes no neg negative 2 neg 02.06.2015 positive 1 positive 1
33 2914 guruvammal 70 female yes no 1 1 positive 1 not available 03.06.2015 positive 1 positive 1
34 2993 mariappan 30 male yes no 1 1 positive 1 positive 06.06.2015 positive 1 positive 1
35 2915 kalyani 40 female yes no neg neg negative 2 not available 03.06.2015 positive 1 positive 1
36 3007 lakshmi 55 female yes no neg neg negative 2 not available 08.06.2015 negative 2 negative 2
37 3010 nainar 58 male yes no 1 2 positive 1 not available 09.06.2015 negative 2 negative 2
38 3011 subramaniam 37 male yes no neg neg negative 2 positive 09.06.2015 negative 2 negative 2
39 3012 ponnuvel 43 male yes no neg neg negative 2 not available 09.06.2015 negative 2 negative 2
40 3021 bakiyanathan 48 male yes no 1 2 positive 1 neg 09.06.2015 negative 2 negative 2
41 3023 selvi 27 female yes no neg neg negative 2 positive 09.06.2015 negative 2 negative 2
42 3015 sudalai 65 female yes no neg neg negative 2 neg 09.06.2015 negative 2 negative 2
43 3027 sanmugapandi 56 male no yes neg neg negative 2 neg 09.06.2015 negative 2 negative 2
44 3028 vellapandi 75 male yes no neg neg negative 2 neg 10.06.2015 negative 2 negative 2
45 3024 ganeshan 56 male yes no 1 2 positive 1 neg 09.06.2015 negative 2 negative 2
46 3026 mani 48 male yes no 3 3 positive 1 neg 09.06.2015 negative 2 negative 2
47 2955 kulandhai 35 male yes no neg neg negative 2 neg 05.06.2015 negative 2 negative 2
48 2930 beema 28 female yes no neg neg negative 2 neg 03.06.2015 negative 2 negative 2
49 2940 paramisvam 55 male yes no neg neg negative 2 not available 04.06.2015 negative 2 negative 2
50 3003 ponnusamy 69 male yes no 3 3 positive 1 not available 08.06.2015 negative 2 negative 2
Page 1
